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ABSTRACT    
 
 
The aim of this study was to evaluate patterns and consequences of acute circulatory failure and 
to study possible problems in the calculation of the severity scores and outcome prediction based 
on them. The signs of acute circulatory failure were studied with the pattern of lactate and 
lactate/pyruvate ratio in emergency admission patients. Hemodynamic profile and oxygen 
transport variables of patients with acute circulatory were studied in relation to resuscitation 
outcome and development of multiple organ failure. The bias resulting from different data 
collection methods for the severity score calculation was studied by stepwise elevation of the 
sampling rate. The accuracy of outcome prediction based on the severity scores was studied in 
patients with prolonged stay using recalibrated models of outcome prediction in a large national 
intensive care database. 
 
Prolongation of lactate elevation over 6 hours was associated with increased risk of death 
compared to patients with normal lactate. Simultaneous elevation of lactate and lactate/pyruvate 
ratio was associated with increased mortality, but the predictive value of lactate and 
lactate/pyruvate ratio was similar to the measurement of lactate with acid-base status. 
Responders of resuscitation of acute circulatory failure defined as clearance of elevated lactate 
and base deficit in 24 hours showed higher mean arterial pressure at 24 hours after admission 
but no other differences in parameters of circulation and oxygen transport could be found. Non-
responders of resuscitation developed a more severe multiple organ failure. The severity of 
multiple organ failure and late propagation of organ failures were associated with increased 
mortality. Severity scores are biased if the sampling methods are changed because increasing the 
sampling rate of data collection for the severity score calculation resulted in higher APACHE II 
and SAPS II scores. Outcome prediction based on the severity scores collected on the first day 
of ICU care can not be used in patients with prolonged care because the prediction models lose 
their predictive power as their stay in intensive care prolongs.  
 
 
 
 
 
 
 
 
 
National Library of Medicine Classification: WG 106, WX 218 
 
Medical Subject Headings: shock; multiple organ failure; severity of illness index; treatment 
outcome; predictive value of tests; hospital mortality; acute disease; hemodynamics; intensive 
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1 INTRODUCTION 
Before the advent of modern intensive care methods and technology, patients with severe 
injury or illness were most likely to die during the initial resuscitation period. Today patients 
survive the first days after insult through sophisticated therapeutic interventions. A prolonged 
resuscitation period activates several defence mechanisms in the human body, which then lead to 
a series of secondary reactions. The clinical picture resulting from the activation of these cascades 
and defence mechanisms (systemic inflammatory response syndrome or SIRS) is a reaction of the 
organism to the triggering insult and is very similar to the response to an infection (Bone, et al. 
1992b). If the activation period is long and severe enough, the cells become temporarily 
malfunctioning and focal necrosis can occur leading to clinically manifest organ dysfunction (Fry 
2000, Koch and Funk2001). This syndrome is today known as multiple organ failure or MOF. 
MOF is the main cause of death after prolonged intensive care and it has been in the focus of 
intensive scientific work for more than 2 decades (Deitch 1992). MOF concerns all main functions 
of the body. Because of the multitude of clinical pictures of MOF, several scoring systems have 
been developed with the aim to describe the syndrome in a better way (Marshall, et al. 1995, 
Vincent, et al. 1996). The pattern of MOF may influence the ultimate outcome of the patient and 
scoring systems can be used to describe the course of the syndrome. 
Most acute disorders leading to intensive care admission are either directly or indirectly 
related to circulation. The term shock is defined as a state where blood circulation cannot maintain 
sufficient oxygen supply to the tissues and organs. Clinical signs of shock are therefore more 
closely related to the consequences of shock rather than hemodynamic alterations leading to it. 
The signs of shock become apparent when compensatory mechanisms of oxygen supply are 
exhausted. Metabolic indicators of shock and circulatory failure include signs of anaerobic 
metabolism, such as increased arterial concentrations of lactate (Weil and Afifi 1970) and 
metabolic acidosis (Kincaid, et al. 1998), especially lactic acidosis (Mizock and Falk 1992). The 
role of lactate in health and disease has been studied extensively during the last century and 
information of the etiology of hyperlactatemia in various settings has emphasised its role as a 
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valuable variable in the monitoring of critical care patients. Most often lactate elevation is related 
to hypoperfusion. However, new evidence suggests that lactate can be produced in compartments 
of well-perfused tissues through epinephrine-stimulated Na+, K+-ATPase activity in patients with 
injury and sepsis (James, et al. 1999). Elevated lactate levels with or without concomitant 
metabolic acidosis as a measure of exhaustion of compensatory mechanisms and its pattern during 
the resuscitation period is under ongoing debate.  
Objective assessment of the severity of acute illness is challenging. Several scoring systems 
have been developed for the purposes of assessing this severity. The most widely used systems are 
the APACHE II (Knaus, et al. 1985a) and SAPS II (Le Gall, et al. 1993). These systems combine 
variables of acute physiological alterations with measures of chronic illness and age of the patient. 
Because many of the variables contained in the scores may change rapidly during critical illness, 
the sampling rate may have a great impact on the resulting score, and thus on the perceived 
severity of the illness (Bosman, et al. 1998). Computer technology has made it possible to collect 
data automatically with high resolution, daily providing large amounts of data points for each 
patient. The selection of the appropriate data points for the severity score variables may have a 
fundamental impact on the severity scores and is a major potential cause of bias. Though the issue 
itself has been recognised, its quantification is still lacking. Mortality prediction models based on 
severity scores emerged from the assumption that severity of acute illness is directly related to 
mortality. The performance of commonly used severity scores, measured on their discriminatory 
power and calibration, is good in many patient populations (Wong, et al. 1995). The bias resulting 
from different patient populations can partly be eliminated with recalibration of the prediction 
models to the patient population on which they will be used. Because many patients die in the 
very first days of their stay in the ICU, the developed models might be biased to favour this group 
of patients. Patients staying for more than 7 days in the ICU are a minority in number but 
consume half of all ICU –resources. Therefore, the prediction of mortality in this patient 
population might be even more warranted (Oye and Bellamy 1991). The impact of ICU-length of 
stay on the prediction tools has not been studied with recalibrated models in sufficiently large 
patient populations yet. 
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The aims of this study were to study the patterns of lactate and L/P-ratio in the early phase of 
emergency admissions to the ICU and their role as predictors of outcome. Second aim was to 
study the hemodynamic profiles associated with the success of resuscitation of acute circulatory 
failure and the outcome of acute circulatory failure in terms of mortality and MOF. Third aim was 
to measure the bias caused by different data collection methods of APACHE II and SAPS II 
scores. The forth aim was to study the reliability of the mortality prediction tools based on 
APACHE II and SAPS II scores in patients with prolonged length of stay in the ICU. 
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2 REVIEW OF THE LITERATURE 
2.1 Multiple organ failure  
2.1.1 MOF and the use of ICU-resources 
Multiple organ failure (MOF) or multiple organ dysfunction syndrome (MODS) is the 
leading cause of death in patients with prolonged length of stay in the intensive care unit (ICU -
LOS, Deitch 1993). Nearly 100% of patients with ICU-length of stay (ICU-LOS) over 10 days 
have MOF and the more severe the MOF the longer the ICU-LOS (Barie and Hydo 1996). MOF 
was initially understood as an uncontrolled infection (Fry, et al. 1980) but is recently considered 
as a potentially temporary malfunction of organs and organ systems distant from the initial event 
(Baue1994, Bone, et al. 1992b). The term MODS (multiple organ dysfunction syndrome) was 
introduced to replace the term failure as it was emphasised that the organ systems were not 
capable of maintaining sufficient organ function and homeostasis and that the organ dysfunction 
was sometimes only relative (Bone, et al. 1992b). Dysfunction can also be understood as being 
something temporary and dynamic, not a state but a process (Bone, et al. 1992b). It is a syndrome 
in the sense that MOF forms a group of symptoms that together are characteristic of a specific 
condition (Webster’s Encyclopedic Unabridged Dictionary, Gramery Books, New York, 1996). 
MOF is triggered by various initial insults like trauma, surgery, infection, sepsis, septic shock, 
burn injury and intoxication among others. MOF associated with trauma has served as a model for 
investigation because the interval between triggering event and development of MOF can be 
assessed precisely and primary organ injury can be easily separated from remote organ 
dysfunctions. Also, trauma patients are younger and comorbid conditions do not compromise the 
possibilities of the patients to survive (Sauaia, et al. 1996). In recent years, research has focused 
on 3 aspects of MOF; 1) association between initial event especially SIRS and development of 
MOF, 2) factors associated with the severity of MOF and 3) attempt to describe and grade the 
course of MOF during the ICU-stay.  
2.1.2 Quantification of MOF 
Because the clinical picture of MOF is different in every patient and degree of organ failure 
varies, scoring systems have been developed with the aim to characterise MOF in terms of 
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numbers and degrees of severity. These systems may also help to analyse the course of the 
syndrome in large patient groups and identify general characteristics among them. Organ failure 
assessment has followed two principally different approaches; 1) by a dichotomous assessment of 
failure as present or absent or 2) by grading of organ systems dysfunction into varying levels of 
severity and by forming a sum figure to grade the severity of multiple organ failure. The first 
organ failure assessment, OSF (organ system failure) graded 5 organ system failures (circulation, 
respiration, renal, hematological, neurological) as present or absent based on definitions for each 
organ failure (Knaus, et al. 1985b). This grading system was used on a daily basis. The results of 
the first publication based on analysis of 5677 ICU-admissions in 13 hospitals from the year 1979 
to 1982 revealed that there is a relationship between duration and number of organ failures and 
mortality. If 3 or more organs were failing for longer than 3 days, mortality was over 90%. The 
results of this report were used for several years as a criterion to withdraw intensive care of 
patients with sustained organ system failures. The same group published an analysis of 7703 
patients from the year 1988 to 1990 using the same organ failure assessment (Zimmerman, et al. 
1996). They showed that the survival rate of patients with three or more organ failures lasting 4 
days or longer was better than in patients one decade earlier. However, the mortality of patients 
with three or more organ failures for at least 4 days was still over 80% indicating that MOF still 
was the main cause of death after prolonged intensive care. Though the mortality of patients with 
more than 3 organ failures for several days is high, it is not 100% and therefore the decision to 
withdraw treatment cannot be based on the OSF-scores alone. High risk of death indicates that 
many of the patients will die, but it cannot answer exactly who are the survivors. 
Several semi-quantitative scoring systems have been developed for grading of MOF. Three 
scoring systems that have gained most popularity are MODS-score, (Marshall, et al. 1995), 
SOFA-score (Vincent, et al. 1996) and logistic organ dysfunction (LOD)-score (Le Gall, et al. 
1996). MODS- and SOFA-scores are based on quantification of organ failures into 5 grades of 
severity based on physiologic or laboratory threshold values (Table 2-1). There are minor 
differences between these two systems about which variables are used to describe organ 
dysfunction. Neither of them contains gastrointestinal failure. 
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Table 2-1 Comparison of MODS score and SOFA scores. 
SOFA Variable  1 2 3 4 
Respiratory PaO2/FiO2 <400 <300 <200a <100a 
Hematologic Platelets 109/L <150 <100 <50 <20 
Hepatic Bilirubin mmol/L 20-32 33-101 102-204 >204 
Cardiovascular 
Hypotension/ 
Inotropes  
MAP 
<70mmHg 
D <5 or DB 
(any dose)b 
D >5,or E<0.1 
or NE <0.1 b 
D > 15 or E >0.1 
or NE > 0.1 b 
Cerebral GCS 13-14 10-12 6-9 <6 
Renal Creatinine mmol/L 
Urine output ml/d 
110-170 
 
171-299 
 
300-440 or 
< 500 
>440 or 
< 200 
MODS  1 2 3 4 
Respiratory PaO2/FiO2 226-300 151-225 76-150 <76 
Hematologic Platelets 109/L 81-120 51-80 21-50 <21 
Hepatic Bilirubin mmol/L 21-60 61-120 121-240 >240 
Cardiovascular PAR 10.1-15.0 15.1-20.0 20.1-30.0 >30.0 
Cerebral GCS 13-14 10-12 7-9 <7 
Renal Creatinine mmol/L 101-200 201-350 351-500 >500 
 
PAR (pressure adjusted heart rate) = HR x CVP/MAP 
HR = heart rate 
CVP = central venous pressure 
MAP = mean arterial pressure 
a on respirator  
b D = dopamine, DB = dobutamine, E = epinephrine, NE = nor-epinephrine, dosages expressed in 
mg/kg/min. Vasoactive infus ion must last for at least 1 hour. 
 
MODS-score was developed in a single unit using data of 692 patients. For MODS-score six 
organ systems are graded into 5 levels of severity ranging from zero, which equals to normal 
function, to 4, which equals to most severe failure. The organ specific scores are summed to give 
the final score. The maximum of MODS-score is thus 24. MODS-score was primarily constructed 
to quantify MOF for the whole period of ICU-stay but can also be calculated on a daily basis. 
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SOFA-scores were initially calculated daily and later applications constructed sum-functions 
for quantification of MOF for the whole ICU-period. The SOFA-score is calculated in a similar 
fashion as the MODS-score. The original abbreviation of the SOFA (Vincent, et al. 1996, Moreno, 
et al. 1999), Sepsis-related Organ Failure Assessment score was later modified to indicate 
Sequential Organ Failure Assessment. (Moreno, et al. 1999, Vincent, et al. 1998). 
The third organ failure assessment system, the logistic organ dysfunction system (LOD-
score), which was based solely on the data of the first ICU-day, graded the 6 organ failures from 1 
to 3 levels of severity and LOD-points were assigned according to the level of severity from 0 to 
5. (Le Gall, et al. 1996). Relative weights were determined using logistic regression techniques. 
The final score ranging from 0 to 22 was converted to a probability of hospital death. LOD-score 
was more a method to describe organ dysfunction very early during the ICU-stay. This review will 
concentrate on the SOFA and MOD-scores, because the data collection of the original LOD-score 
is limited to the first ICU-day and is therefore not a method to describe later development of MOF 
as a consequence of a primary insult.  
The most important difference between the two systems of MODS and SOFA in selection of 
the threshold values lies in the assessment of circulatory failure. The PAR or “pressure-adjusted 
heart rate” of the MODS-score (Table 2-1) is calculated as the product of heart rate and CVP 
divided by MAP. PAR increases if signs of hypovolemia, such as tachycardia, low CVP and low 
MAP are present. The higher the PAR the more points are assigned to the score. Such an interim 
value is not calculated on a routine basis and in order to find the “worst” value during each 24 
hours period it has to be recorded at least once an hour. On the lowest level of severity the SOFA-
score for the circulatory failure is graded related to a threshold level of mean arterial pressure and 
on the higher levels of severity to the need and doses of sympathomimetic medication. A time-
related condition is defined only for sympathomimetic medication; the threshold dose has to last 1 
hour at least. For other organ failures in SOFA-score and MODS-score applies that duration of 
any status is not predefined in order to be qualified for inclusion to the scoring. In MODS-score 
the clinical and laboratory data were collected at a certain time each day. The importance of this is 
diminished by the fact that renal, hepatic and hematologic organ system failures are improving or 
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worsening slowly and a rapid progression in either direction within 24 hours is not anticipated. In 
contrast, circulatory failure (measured as PAR or mean arterial pressure and sympathomimetic 
drug infusion), respiratory failure (measured as PaO2/FiO2) and neurological condition (measured 
as GCS) can change rapidly and short episodes of deterioration are possible.  
None of the grading systems of MOF include a measure for intestinal failure. Because of 
difficulties in determining the level of intestinal failure on continuous or semi-continuous basis it 
has been omitted in the scores (Marshall, et al. 1995). Intestinal failure seems not to be the most 
important risk factor of mortality in patients with MOF (Tran, et al. 1990, Hebert, et al. 1993, 
Kollef and Sherman 1999). However, the intestinal tract is an important trigger or amplifier of 
distant organ failures (Moore 1999). The changes in the intestinal region induced by SIRS play an 
important role in the development of MOF (Doig, et al. 1998). The circulation of splanchnic area 
is reduced as a result of compensatory reactions during various states of shock and if the 
resuscitation is prolonged or insufficient, a protracted period of splanchnic ischemia with release 
of inflammatory mediators results (Kirton, et al. 1998). This is followed by the development of 
remote organ failures. Also, nutritional issues aiming at conserving the integrity of the mucosal 
layer of the intestinal tract play a role in the development of MOF. Early enteral nutrition (Kudsk 
1994, Borum, et al. 2000) and parenteral glutamine supplementation (Griffiths 1997) can reduce 
severity of MOF, complications and mortality in specific patients groups. 
 
2.1.3 The clinical picture and time -pattern of MOF  
The 1992 consensus conference report outlines the associations between SIRS, sepsis and 
MOF (Bone, et al. 1992b). SIRS is a reaction of the body to an insult (Table 2-2). Any severe 
insult like trauma, circulatory shock, pancreatitis, burn injury or infection can lead to SIRS. If 
SIRS is associated with infection the condition is defined as sepsis. The definition of SIRS 
contains 5 aspects of a very complex clinical condition and the variables are weighted as present 
or absent. The duration of the SIRS-variables has not been defined but they have been recorded as 
present if they appear on the patient records. SIRS is present if two or more of the variables are 
present simultaneously and thus a grading of SIRS into categories of severity is possible according 
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to the number of variables exceeding the threshold limit. The general nature of SIRS is 
demonstrated by the fact that many physiological and normal situations of healthy people fulfil the 
criteria of SIRS e.g. heavy physical exercise. As such the SIRS is not a syndrome because it does 
not have a unique cause but it is more a context, and it is quite sensitive but non-specific 
(Marshall2000, Levy, et al. 2003b). 
 
Table 2-2 The definition of systemic inflammatory response syndrome (SIRS). 
At least two of the following need to be present. 
Variables Limits 
Temperature > 38 or < 36°C 
Heart rate  > 90/min 
Respiratory rate or 
PaCO2 
>20/min 
<4.3kPa 
White blood cells 
12 000/mm3 or 
< 4000/mm3 or 
> 10% immature forms 
 
Almost all patients are admitted to the ICU with the picture of SIRS (Pittet, et al. 1995). If 
the duration of SIRS prolongs there is a greater danger for the development of MOF (Haga, et al. 
1997, Bown, et al. 2003). Successful resuscitation of the early ICU-care can be documented by a 
decrease of SIRS-score, which is equal to the number of SIRS-elements (Talmor, et al. 1999). It 
seems that the prolongation or reappearance of SIRS is more important in terms of MOF-
development than the severity of SIRS per se. SIRS often precedes sepsis and septic shock. This 
was shown by Rangel-Frausto et al. According to their research, nearly half of patients with sepsis 
had a preceding SIRS several days before (Rangel-Frausto, et al. 1995). The study showed further 
that the more criteria of SIRS were present, the higher was the rate of ARDS, acute renal failure, 
disseminated intravascular coagulation and shock. Mortality increased in a stepwise fashion from 
3 to 17% as the number of SIRS-components increased from 0 to 4. In contrast, the presence or 
the number of inflammatory response criteria during sepsis were not prognostic for the outcome in 
a large multicenter study by Alberti et al. in patients with sepsis (Alberti et al. 2003). They 
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identified comorbid conditions, severity of acute illness, organ dysfunction, presence of infection 
and the type of microbes to be prognostic for the outcome.  
 The scoring systems of MOF do not include limitations that consider the term MOF as a 
secondary phenomenon only. Organ failures are scored if they meet the definitions irrespective of 
the time point. Many patients fulfill the criteria of organ failure already on the day of admission. 
This is very possible if the patient has been treated at least some days in hospital and the 
triggering insult has occurred in the ward e.g. as a result of infection and operation. It could also 
be possible that an infectious disease has started at home and patient will be admitted to hospital 
with established organ failures. However, this has led to the confusing discussion about primary 
and secondary MOF. If MOF is considered e.g. a consequence of injury or shock, it should not be 
present in patients admitted to the ICU directly from the trauma scene. Knaus (Knaus, et al. 
1985b) reported that 79% of patients with organ failures entered the ICU with at least one organ 
system failing and 21% of patients developed organ failures after the first day in the ICU. From 
those who developed organ system failures later, did so on the third day at the latest. In a study 
using a modified MODS-score in trauma patients (Cryer, et al. 1999), 72% of patients had MOF 
on the first day. Patients with severe MOF reached that level in 67% of the cases on the first day 
of ICU care. In order to avoid primary SIRS and incomplete resuscitation to be mixed up with 
MOF, other investigators have included MOF only, if it appears after 48 hours of care (Sauaia, et 
al. 1996). 
In order to separate MOF from SIRS many studies of post-injury MOF have used a modified 
MODS-score omitting the assessment of neurological and coagulation systems (Sauaia, et al. 
1998, Cryer, et al. 1999). The grading of neurological failure using Glasgow coma scale (GCS) is 
always subjective and can be hampered by sedative drugs. The most applied MODS-score for 
trauma patients consists thus from 4 organ failures: 1) respiratory, 2) renal, 3) hepatic and 4) 
cardiac failure (Sauaia, et al. 1994). Respiratory dysfunction is graded with an ARDS-score 
including radiological findings, oxygenation, minute ventilation, level of positive end expiratory 
pressure and static compliance. Cardiac function is graded using dosages of inotropic medication. 
Renal function is measured with creatinine and hepatic function with bilirubin levels. This score 
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should be used after 48 hours from the injury only, in order not to include rapidly reversible 
abnormalities of the early SIRS (Sauaia, et al. 1994). Patients of older age develop a more severe 
posttraumatic MOF than younger patients after injury of similar severity (Goris, et al. 1985). The 
age might not be independently associated with MOF because older patients have often 
concomitant diseases, which complicate the resuscitation and stabilisation period and make them 
prone to developing a more severe MOF (Tran, et al. 1993). The development of posttraumatic 
MOF is related to the severity of the trauma (Sauaia, et al. 1994). Need for blood transfusions in 
the early resuscitation period is shown to be associated with the development of MOF and the 
need of blood transfusions can be seen as an surrogate of trauma severity (Sauaia, et al. 1998, 
Tran, et al. 1993). Also the need of crystalloids is associated with the severity of injury and thus 
also with severity of MOF (Regel, et al. 1996). In patients with severe trauma (ISS > 24) the 
incidence of MOF was 45% in patients receiving more than 6 units of RBC but 10 % in patients 
receiving 6 units or less. One exception in the association of trauma severity and MOF is brain 
damage. Severe brain damage (GCS <8) is not associated with the development of MOF (Sauaia, 
et al. 1994). Lactate can be seen as an indicator of the severity of shock. Lactate levels of first 
ICU-day are associated with the risk of MOF (Sauaia, et al. 1994, Sauaia, et al. 1996, Moore, et al. 
1996). Because base deficit values can be considered surrogates of the severity of shock as well, 
their association with development of MOF is not surprising (Moore, et al. 1996, Sauaia, et al. 
1996, Regel, et al. 1996, Cryer, et al. 1999). 
The respiratory failure has a unique role in the development of MOF. The first organ failure 
to show deterioration is the respiratory system (Fry, et al. 1980, Sauaia, et al. 1994, Regel, et al. 
1996, Russell, et al. 2000). This view is very uniformly established in the literature. The 
maximum failure of respiratory function is reached within few days of ICU-care (Vincent, et al. 
1998, Russell, et al. 2000). The position of the lungs in the circulation as the first filter to receive 
the debris, toxins, activated leukocytes and cytokines predisposes them as the place of action. As a 
result there are changes of permeability and albumin extravasation with the clinical picture of non-
cardiogenic pulmonary oedema (Wisner and Sturm1986, Regel, et al. 1996). Occasionally the 
lungs are directly affected by the trauma as in the cases with pulmonary contusion, aspiration of 
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blood or gastric contents and smoke inhalation. The definitions of ALI and ARDS contain same 
quantification variables of oxygenation failure as MOF-scores. If the oxygenation failure is 
accompanied with radiological findings of the lungs, the case fulfils the criteria of ARDS. The 
order of appearance of other organ dysfunctions after respiratory failure is less uniform. Many 
publications place the liver on the second place in the order of appearance in trauma patients (Fry, 
et al. 1980, Goris, et al. 1985, Regel, et al. 1996). If liver failure is present, it is commonly 
developed after third day post-injury (Moore, et al. 1996) and the maximum of the liver failure is 
commonly reached after 4 to 5 days of ICU-care (Marshall, et al. 1995, Vincent, et al. 1998). 
Renal, hematological and cardiovascular failures reach their peak values of SOFA and MODS-
scores in 3 to 4 days of ICU-care. The differences of the patient populations and patient selection 
in the studies of Marshall et al and of Moreno et al could explain the great difference in the 
occurrence and timing of CNS-failure. In surgical patients the maximum CNS-failure was reached 
in 4.1 days (Marshall, et al. 1995). In contrast, mixed ICU-patients reached their maximum CNS-
failure after 1.6 days. (Moreno et al, 1999) 
The contribution of specific organ failures to the risk of death is not equal and can vary in 
different patient populations. Though the respiratory failure is highly associated with mortality in 
trauma patients (Regel, et al. 1996), its role is not so important in mixed ICU patients (Moreno, et 
al. 1999). Also, the time of treatment has an impact. The association of the respiratory failure with 
mortality is present only if a worsening of the respiratory dysfunction occurs in the second week 
of treatment (Cook, et al. 2001). There is a strong association of the circulatory dysfunction with 
mortality and this association is not time-dependent. (Marshall, et al. 1995, Moreno, et al. 1999, 
Cook, et al. 2001). The late circulatory dysfunction and resistance to inotropic support in the late 
stages of MOF are often signs of final decompensation of MOF and precede death. CNS 
dysfunction is highly associated with mortality in surgical patients (Marshall, et al. 1995) as well 
as in mixed ICU patients (Moreno, et al. 1999). In medical patients the organ systems with the 
strongest contribution to hospital mortality were hepatic, cardiovascular and respiratory failures in 
the order of decreasing risk ratio (Janssens, et al. 2000). Russels used a different study approach 
and estimated organ failures at baseline and 3 days later as worsening or improving of the status. 
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He showed that 30-day mortality of patients with sepsis was associated with worsening of 
neurological, coagulation and renal function over the first 3 days of the ICU care (Russell, et al. 
2000). Interestingly, the severity of the first day respiratory failure or worsening respiratory 
function over the first 3 days was not associated with mortality, which finding is similar to that of 
Cook et al. (Cook, et al. 2001). 
2.1.4 Repeated measurement of organ failure scores 
MODS- score and SOFA-score are very similar to each other especially after calculation of 
total maximal SOFA-score, abbreviated as TMS-score. TMS score is calculated by summing the 
maximum individual organ scores ever reached during the ICU-stay. Thus, TMS and MODS-
score both represent the total of organ failures during the whole ICU-stay. Delta-SOFA, 
understood as the TMS minus admission SOFA is the same as delta-MODS, calculated as the 
increase of the MODS-score from the admission to the total MODS-score. Two reports, one 
dealing with delta-MODS (Marshall, et al. 1995) and the other with delta-SOFA (Moreno, et al. 
1999) have found exactly the same association between organ failure score increase after 
admission and mortality. Both found a nearly linear rise of mortality from 0 or 10%, up to 80% as 
the score either remained the same or increased maximally. The admission scores contributed as 
strongly as the difference of the scores between admission and the maximum scores to the 
predictive power.  
When comparing the variables contained in severity scores and MOF-scores one can notice 
that the differences are small. The variables of the severity scores are more often rapidly changing 
than those of MOF-scores, except of PaO2/FiO2, GCS and PAR, respectively, MAP or dose of 
inotropic medication. Because MOF-scores contain also rapidly changing variables they can be 
sensitive to differences in the data collection practices. If MOF-scores are collected on a fixed 
time point of the day, it is important that the time point reflects the average of the patients’ status. 
The duration of each failure has not been addressed in the literature. 
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2.2 Circulatory failure  as the cause of multiple organ failure  
2.2.1 Tissue hypoxia and hypoperfusion 
A shock is present if the perfusion and thus the oxygenation of vital organs is threatened or 
compromised. Traditionally shock is divided into hypovolemic, cardiogenic, obstructive and 
distributive shock. These are, however, not mutually exclusive entities but often also 
simultaneously present as e.g. in patients with sepsis or severe trauma, where hypovolemic, 
cardiogenic, and distributive components all are present. The definition of shock based on the 
oxygenation of organs implies also that a predefined level of blood flow or blood pressure, which 
could be considered sufficient to guarantee organ oxygenation, cannot be determined. It depends 
on the temporary needs of the organs and they vary e.g. in relation to temperature and metabolic 
activity. The main determinant of oxygen delivery at the whole body level is cardiac output 
because it can vary in a much larger scale than the components of oxygen content, SaO2 and 
hemoglobin.  
2.2.2 Blood pressure and flow 
All severity scores include variables of blood pressure. Blood pressure is directly related to 
stroke volume and vascular resistance and dependent on a multitude of control and compensation 
mechanisms of the body. A seemingly adequate blood pressure does not guarantee sufficient 
blood flow. The correlation between cardiac index and blood pressure is poor (Wo, et al. 1993) 
and thus cardiac index cannot be estimated from blood pressure (Abou-Khalil, et al. 1994). Low 
blood pressure is often quoted as shock and the degree of shock is a measure for the severity of 
trauma. Many studies have found an association between shock and development of MOF (Faist, 
et al. 1983, Henao, et al. 1991, Tran, et al. 1993, Sauaia, et al. 1994, Moore, et al. 1996). Other 
investigators were unable to find an association between minimal systolic blood pressure in the 
first 24 hours after injury and severity of MOF in severely injured patients (Cryer, et al. 1999). 
Low flow state can be present even if blood pressure and filling pressures are within normal range 
and occasionally, a low flow state can be suspected with simple clinical indicators such as skin 
temperature (Kaplan, et al. 2001). The pattern of blood pressure of the first day is the result of 
patient physiology and its manipulation by various therapeutic interventions. In selected patient 
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groups even the control of high blood pressure and decreasing peripheral vascular resistance 
might be the key elements of the resuscitation in order to reach good results (Ruokonen, et al. 
1993a, McKinley, et al. 2000). Tachycardia can be a sign of impaired circulatory function and a 
sign of hypovolemia or impaired cardiac function. In a series of 48 mixed type septic patients, 
Parker et al found that heart rate was predic tive to survival (Parker, et al. 1987). Heart rate of the 
survivors was lower and a decreasing heart rate and cardiac index in the 24 hours interval were 
predictive to survival. MAP initially or during 24 hours was not associated with survival.  
2.2.3 Regional circulation  
Hypovolemia and hypoperfusion cause a series of adaptive mechanisms in the body, which 
aim to support the perfusion of vital organs like heart and brain. This is accomplished by diverting 
blood flow away from less vital regions like the splanchnic region, which leads to ischemia, 
cellular dysfunction and disruption of the intestinal barrier (Moore, et al. 1994). 
Ischemia/reperfusion injuries induce activation of the neutrofils and endothelial cells which lead 
to augmented cellular damage. Bacterial translocation and leakage of endotoxins to the blood 
circulation are thought to be major contributing factors to remote organ failures (Swank and 
Deitch 1996). Several studies showed that mucosal ischemia measured with gastric intramucosal 
pH (pHi) or with pCO2-gradient between arterial blood and mucosa (Fiddian-Green 1993), can 
predict MOF and death in various critically ill patient populations (Marik 1993, Maynard, et al. 
1993, Kirton, et al. 1998, Poeze, et al. 2000, Levy, et al. 2003a). Gutierrez at al studied a group of 
sepsis patients with a pHi < 7.32 (Gutierrez, et al. 1994). This level is often considered to be 
associated with impaired splanchnic circulation. Dobutamine infusion increased oxygen delivery 
with no changes in oxygen consumption. High lactate levels decreased. Gastric pHi values 
increased in patients with normal as well as high lactate levels. Others have not repeated these 
results with similar consistency. Measurement of pCO2 gradient can serve as a predictor of 
outcome, but probably not as a goal of treatment (Mythen and Webb 1994, Mythen, et al. 1993). 
The unpredictability of regional circulation by hemodynamic manipulation has limited the clinical 
usefulness of pCO2-gap measurement in patient care (Jakob, et al. 2000,Marik and Mohedin 
1994, Ruokonen, et al. 1993b). Development and propagation of MOF is not solely resulting from 
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circulatory impairment but the activation of cytokine response and other defence mechanisms are 
much involved. This was brought up by Gebbert et al. who found that the cytokine levels of 
patients in MOF resulting from cardiogenic shock were as high as of patients with sepsis 
(Geppert, et al. 2002). 
2.2.4 Oxygen debt and flow-dependency 
Oxygen debt was introduced into the medical practice by Shoemaker who showed in high 
risk surgical patients that the greater the oxygen debt, the worse the outcome in terms of mortality 
and MOF (Shoemaker, et al. 1992). This cumulative oxygen deficit or oxygen debt, introduced in 
the sixties through animal studies, is calculated as the time integral between estimated oxygen 
need and actual oxygen delivery. The most important hemodynamic variable related to the oxygen 
debt and associated with outcome has been shown to be cardiac index (Shoemaker, et al. 1992). 
The concept of oxygen debt has been criticised because debt is considered as something that can 
be paid back. Triggering events for the development of MOF emerge during the hypoperfusion 
and the development of MOF cannot be prevented even though the period of hypoperfusion is 
followed by a period of hyperperfusion and thus oxygen debt cannot be paid back. Oxygen 
consumption can vary considerably and significant increases can be induced e.g. by physiotherapy 
resembling changes seen during physical exercise (Weissman and Kemper 1993). During 
hypoperfusion, blood flow is diverted to vital tissues and augmentation of flow will subsequently 
improve the blood flow through tissues, whose circulation was temporarily impaired. 
Oxygen consumption is flow-dependent if oxygen delivery to the tissues is limiting the 
oxygen consumption. Oxygen delivery is mainly influenced by the blood flow. If oxygen delivery 
is enhanced in a flow-dependent situation, oxygen consumption will rise, revealing occult sites of 
hypoperfusion. Oxygen consumption becomes flow-dependent when the physiological 
compensation mechanisms, like local adaptation of regional circulation, microcirculation and 
increased oxygen extraction, are exhausted. Oxygenation is non-flow dependent if blood lactate is 
normal and oxygen consumption does not rise as a result of augmentation of circulation 
(Abramson, et al. 1993). Non-flow-dependency has been used as a proof that all organs are 
sufficiently perfused. Flow-dependency might be different in sepsis and septic shock than in other 
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patients with critical illness, especially trauma. Some early studies demonstrated the presence of 
flow-dependency also in sepsis (Haupt, et al. 1985, Astiz, et al. 1987), but later studies have 
questioned this (Manthous, et al. 1993, Ronco, et al. 1993b,Gore, et al. 1996). Incomplete 
hemodynamic resuscitation can simulate the flow-dependency (Ronco, et al. 1993b). Using same 
parameters for the measurement of oxygen delivery and oxygen consumption will lead to 
mathematical coupling of the data (Archie 1981). This is the case, if reversed Fick-principle is 
used for the determination of oxygen consumption because CI is used for calculation of oxygen 
delivery as well as for oxygen consumption. Also ARDS patients showed no flow-dependency as 
oxygen delivery was improved by changes of respirator settings and oxygen consumption was 
measured independently from delivery measurement by mass spectrometry (Annat, et al. 1986). 
The impairment of cellular oxygenation during sepsis is often not related to circulation at all. 
Sepsis can induce malfunction of the mitochondria by disturbing cellular respiration and energy 
production leading to cellular death and organ dysfunction (Brealey, et al. 2002). 
2.2.5 Goal directed therapy 
A series of studies started in the seventies by the Shoemaker group found that survivors of 
shock (Shoemaker, et al. 1973), injury (Bishop, et al. 1993), high risk surgery (Shoemaker, et al. 
1988) and sepsis (Shoemaker, et al. 1993) had higher oxygen delivery and oxygen consumption as 
well as higher cardiac output in early phases of their illness compared to non-survivors. This 
observation led to the concept of supranormal values of oxygen delivery and cardiac output as 
goals of treatment in various patient populations. Augmentation of oxygen delivery can be 
accomplished by optimising cardiac filling pressures, by increasing the hemoglobin concentration 
and by giving inotropic agents. This concept was widely accepted and studied in various patient 
populations. Better outcomes have been reported in patients with septic shock (Edwards, et al. 
1989), with severe trauma (Fleming, et al. 1992, Bishop, et al. 1995) and with high-risk surgery 
(Shoemaker, et al. 1988, Boyd, et al. 1993). Most often hemodynamic goals were set to oxygen 
delivery of 600ml/min/m2 and oxygen consumption of 150-170 ml/min/m2. All studies could not 
confirm a favourable effect of this concept on outcome (Hayes, et al. 1994, Gattinoni, et al. 1995, 
Durham, et al. 1996, Alia, et al. 1999, Takala, et al. 2000, Velmahos, et al. 2000). Intention to 
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treat basis of the study set-up was often disturbed by spontaneous reaction of some patients to 
reach the study goals without manipulation. This led to the need of subgroup analysis and to the 
conclusion that patients who can, whether induced or spontaneously, elevate their oxygen delivery 
have better outcome (Yu, et al. 1993). Younger patients might have greater benefit of this 
approach or elderly patients do not tolerate the inotropic medication (Hayes, et al. 1994, Durham, 
et al. 1996, Yu, et al. 1998). Younger patients are more often capable to reach optimal goals 
(Velmahos, et al. 2000). In order to be effective, goal directed therapy must be started early and 
the risk of death must be high enough. (Shoemaker, et al. 1988, Bishop, et al. 1995). If organ 
failures are established, augmentation of oxygen delivery to supranormal levels has no effect on 
outcome. The start of goal directed therapy was very early in the study by Rivers in patients with 
severe sepsis and septic shock (Rivers, et al. 2001). Target levels were set to CVP 8-12 mmHg, 
MAP 65-90 mmHg, urine output > 0,5 ml/kg/h and central venous oxygen saturation (measured 
with a specially designed catheter) to > 70%. If the latter goal was not reached with volume and 
red cell substitution, dobutamine was infused. This strategy was started roughly 1.5 hours after 
arrival to the emergency department and used until patients were admitted to ICU, which occurred 
6 to 8 hours later. The goal directed group showed lower hospital, 28-day and 60-day mortality 
and less patients were on respirator during the first 3 days in the ICU. In order to reach the target 
goals, more fluids and blood products will be needed (Bishop, et al. 1995). Negative results in 
elderly patients might reflect diminished cardiac reserves. If the cardiac and metabolic reserves 
are totally exhausted with the disease process or with chronic illness, cardiac function cannot be 
augmented with any kind of therapeutic intervention. Some evidence leading to this direction can 
be seen in the dobutamine-stress-test (Vallet, et al. 1993, Rhodes, et al. 1999). Patients unable to 
increase their oxygen consumption by more than 15% with dobutamine infusion were considered 
non-responders. The mortality of the non-responders was 44.4% compared to 8.7% (p<0.05) of 
the responders in the study by Vallet and 91% and 15% (p<0.01) in the study by Rhodes, 
respectively. The responders were younger and fewer had cancer.  
There are some published attempts to define a critical level of oxygen delivery below which 
tissue oxygenation is not sufficient. Rashkin found in critically ill patients that oxygen delivery 
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below 8 ml/kg/min was associated with marked increases of blood lactate and poor survival rate 
(Rashkin, et al. 1985). In patients anaesthetised for coronary by-pass surgery, the critical level of 
oxygen delivery was estimated by finding the lowest threshold value of oxygen delivery below 
which oxygen consumption started to decline (Shibutani, et al. 1983). The critical level was set at 
330ml/min/m2, which is close to the 8ml/kg/min found by Rashkin. Using the same approach, 
Ronco et al found a critical level of 3,8 ml/kg/min in septic and 4,5 ml/kg/min in non-septic 
patients (Ronco, et al. 1993a). This study was conducted when life support measures were 
gradually withdrawn in patients considered not to be able to survive. Septic shock patients with 
DO2 below 8.5 ml/min/kg had 100% mortality in the series of Tuchschmidt et al (Tuchschmidt, et 
al. 1992). These critical values are far from the optimal goals for oxygen delivery recommended 
e.g. by Shoemaker which might reflect the need for an extra compensation for increased oxygen 
demand because of the stress reaction induced by surgery, trauma and pain as well as by 
respiratory work.  
2.3 Lactate and acid-base abnormalities as signs of circulatory failure  
2.3.1 Lactate as a sign of circulatory failure  
Lactic acid production has been known to be associated with e.g. hypoxia for over 100 years 
(Araki, 1890, referenced by Huckabee 1958a). The most important cause of blood lactate 
elevation is poor tissue perfusion and accompanying lack of oxygen in the tissues. The elevation 
of blood lactate with simultaneous metabolic acidosis is termed as lactic acidosis in contrast to 
states of lactate elevation without acidosis (Stacpoole, et al. 1994). The latter situation is often 
quoted as hyperlactatemia. A precise definition of lactic acidosis does not exist. One definition is 
the combination of metabolic acidosis with arterial lactate > 5 mmol/L (Stacpoole, et al. 1994). 
Pyruvate is the product of glycolytic pathway in the degradation process of glucose in the 
cells’ energy production. Lactate is produced from pyruvate and the reaction is catalysed by the 
enzyme LDH (lactic dehydrogenase). By the reaction NADH+ is oxygenated to NAD. The further 
oxidation of pyruvate to CoA is catalysed by the enzyme PDH (pyruvate dehydrogenase). All 
cells are capable of lactate production. Whether pyruvate is converted to lactate or oxidised 
depends on the concentration of pyruvate and the ratio of NAD/NADH. Other possibilities in the 
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pyruvate metabolism are its transamination to alanine or carboxylation to oxaloacetate or malate. 
The energy the cells need is produced by hydrolysis of ATP to ADP during which Pi and H+ are 
produced in equimolar quantities. If the oxygen supply is adequate the produced ADP is 
reconstituted to ATP by utilising H+ and Pi in the mitochondria. If oxygen supply is inadequate, 
the restitution of ATP is prevented and H+ and Pi are accumulated in the cells, which leads to 
acidosis. The glycolytic pathway of glucose to lactate produces 2 moles lactate and 2 moles ATP. 
If this ATP is used for energy production, again ADP, Pi and H+ are produced and in states with 
adequate oxygen supply, the ADP is regenerated to ATP. As a net result, lactate is produced 
without concomitant acidosis. In cases with cellular hypoxia, energy production by glycolysis of 
glucose to lactate produces also hydrogen ions. The myokinase reaction (or adenylate kinase 
reaction) is present in most cells and can produce energy by hydrolysis of ADP to AMP during 
which H+ is produced but not lactate. This can explain situations where acidosis develops without 
increases in lactate concentrations. (Gutierrez and Wulf 1996) The main cause of lactate 
production in the tissues is the lack of oxygen, which leads to anaerobic metabolism because of 
inhibition of oxydation of pyruvate to acetyl CoA. 
In physiological situations such as after exercise, the accumulated lactate is very rapidly 
taken up by liver, kidney, myocardium, and muscles (Wasserman, et al. 1985, Brooks 1986). The 
same occurs in patients after epileptic convulsions (Vincent, et al. 1983). In both of these 
situations the circulation itself is functioning properly. As mentioned above, the most important 
cause of lactate elevation in intensive care patients is considered to be impaired tissue perfusion, 
but because of the complexity of lactate metabolism and because of the key role of lactate in many 
metabolic pathways, the exact causes of lactate elevation e.g. in trauma patients can be several. In 
order to be able to distinguish between impaired tissue perfusion and other causes of 
hyperlactatemia, the concomitant measurement of lactate to pyruvate ratio (L/P- ratio) has been 
proposed. L/P-ratio was introduced over 40 years ago (Huckabee1958a, Huckabee1958b) with the 
concept that it would reflect the redox-state within the cells. Redox-state is reflected in the relation 
of oxidised to reduced nicotinamide nucleotides (NAD/NADH+). In states with diminished 
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oxygen availability, the balance of the synthesis of lactate from pyruvate would favour the 
production of lactate with resulting increase of L/P-ratio.  
2.3.2 Lactate in sepsis and septic shock 
It was noted decades ago that lactate production can also occur in states were there is no 
obvious lack of oxygen. In septic patients, hyperlactatemia can be found in patients with no signs 
of impaired tissue perfusion and at the extremes also in patients with profoundly hyperdynamic 
hemodynamic pattern. The three basic mechanisms of lactate elevation, diminished uptake by the 
liver, increased production stimulated by catecholamines as well as by other factors, and 
insufficient tissue perfusion because of abnormal distribution of blood flow between organs and in 
organs all play a role. Furthermore, disturbances of oxygen transport within the cell induced by 
sepsis contribute to the lactate elevation. The latter has been demonstrated in studies showing that 
the lactate elevation cannot be cured by augmentation of the hemodynamic function. There are 
several pathophysiological mechanisms for lactate elevation in sepsis and septic shock patients. 
First of all, lactate can be produced because of insufficient oxygen transport in relation to oxygen 
demands of the tissues as discussed above. The role of cellular hypoxia as the only cause of blood 
lactate elevation during sepsis was challenged e.g. by Hotchkiss and Karl (Hotchkiss and Karl 
1992). They noted, based on studies with nuclear magnetic resonance spectroscopy during sepsis, 
that cellular hypoxia  can be present with normal lactate levels, because normally oxygenated cells 
can uptake lactate, and that moderate increases of lactate levels are often not associated with 
metabolic acidosis. Lactate can be produced by direct stimulation of glycolysis (Gore, et al. 1996), 
which can further be augmented by sympathetic stimulation. Lactate uptake by the liver can be 
diminished and result in elevated blood lactate levels (Levraut, et al. 1998). In a more recent 
study, Levraut et al showed by infusion of exogenous lactate that lactate clearance of patients with 
sepsis is low and results in normal or mildly elevated blood lactate levels (Levraut, et al. 2003). In 
this study the basal lactate levels between survivors and non-survivors were equal but low lactate 
clearance was independently related to poor outcome. The presence of lactic acidosis or 
hyperlactatemia has been used as a proof for impaired tissue perfusion and oxygenation, because 
patients with lactic acidosis can increase the oxygen consumption as a result of augmentation of 
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oxygen delivery with fluid therapy and catecholamines. (Haupt, et al. 1985, Gilbert, et al. 1986, 
Astiz, et al. 1987). Lactate can, however, be produced also in hyperdynamic circulatory states 
(Subramanian and Kellum 2000), which diminishes the role of lactate as a sign of impaired 
perfusion. In certain situations, augmentation of oxygen transport by manipulation of circulation 
does not lower the elevated lactate levels as expected or do not result in increased oxygen 
consumption (Ronco, et al. 1993b). In the clinical setting the improvement of systemic circulation 
might not be directed to regional areas with insufficient perfusion (Ruokonen, et al. 1993b). If this 
is the case, the enhancement of oxygen consumption and clearance of hyperlactatemia are no 
longer interrelated. This was shown by Silverman in patients with lactic acidosis and sepsis 
syndrome. The patients received fluids, red cells and dobutamine to increase the oxygen delivery. 
There was no correlation between changes of oxygen consumption and changes in lactate levels 
(Silverman 1991). Especially, the role of catecholamines and the stimulation of glycolysis by 
catecholamines in skeletal muscles as the cause of hyperlactatemia in sepsis has been advocated 
recently (James, et al. 1999) and animal models support this opinion (Luchette, et al. 1998). 
During physical exercise the association of catecholamine levels and lactate levels is well proven 
(Brooks 1986, Brooks 1991, di Prampero and Ferretti 1999). The energy production of the cells 
and mitochondrial function are impaired during sepsis leading to cellular oxygen deficit 
irrespective of hemodynamic status (Brealey, et al. 2002). Although lactate elevation and 
metabolic acidosis occur often simultaneously, in various shock states they result via different 
metabolic pathways. The lack of oxygen leads to accumulation of hydrogen ions because the 
regeneration of high-energy phosphates is inhibited leading to acidosis (Zilva 1978, Vincent 1995, 
Gutierrez and Wulf 1996). Also physical-chemical changes in the concentrations of strong ions 
like potassium, sodium, chloride and lactate of the extracellular fluid have been addressed to be 
responsible for the development of acidosis during lactic acidosis (Balasubramanyan, et al. 1999, 
Kellum, et al. 1998). The lungs of patients with acute lung injury produce large amounts of lactate 
and the lactate production is proportional to the severity of lung injury (Brown, et al. 1996, De 
Backer, et al. 1997, Kellum, et al. 1997, Routsi, et al. 1999). Respiratory muscles contribute to the 
blood lactate levels in respiratory distress and if the oxygen delivery to the muscles cannot match 
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this increase, marked lactate elevation and acidosis develop (Aubier, et al. 1982). Lactate 
elevation in the critically ill patient is thus not only associated with hypoperfusion and tissue 
hypoxia. Lactate elevation is associated with a number of critical situations of intensive care and 
the etiology of hyperlactatemia and lactic acidosis is not uniform. Lactate is a non-specific but 
sensitive indicator of patient´s well being in the intensive care setting. 
2.3.3 Using laboratory test for outcome prediction 
A large number of laboratory tests are taken daily and repeatedly from patients in intensive 
care. Some of the blood tests are essential and routine part of diagnostic and are taken to guide the 
therapy, whereas some are more closely associated with scientific interests. Laboratory tests are 
also used for outcome prediction in the intensive care setting and are an important part of severity 
scores, which will be discussed later. For testing the diagnostic accuracy of a prediction tool 
recommendations have been published (Fischer, et al. 2003, Randolph, et al. 1998). The validity 
and reliability of the prediction has to be reported. Study population and raw data has to be 
reported in detail to allow comparisons to an other group of patients (Fischer, et al. 2003). 
Sensitivity and specificity are calculated. Positive likelihood ratio (LR+) reflects the ratio of the 
probability of having a positive test result with the disease to the probability of showing a positive 
test without the disease. It calculates as LR+ = sensitivity/(1-specificity) and it can be calculated 
on several levels of the test result. LR can always be calculated if the original data is reported to 
allow the construction of a 2 x 2 table with the test result and the outcome. Discriminative power 
of the test is studied with ROC-curves calculating the AUC (area under the curve). The level of 
the test with the best discrimination can be roughly estimated using the curve. The best cut-off 
point is the level where the sum of sensitivity and specificity is maximal.  
Scientific work has identified a number of cytokines which are especially involved with the 
pathogenesis of sepsis and septic shock and thus also with the prognosis of the patients. Severe 
trauma triggers a metabolic response resulting in the clinical picture of SIRS. The metabolic 
response can be measured by determining the levels of host response markers. Tumor necrosis 
factor-a (TNF-a) and interleukin-6 (IL-6) are central mediators of sepsis. Marecaux et al 
compared their prognostic significance with lactate in 38 patients with sepsis (Marecaux, et al. 
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1996). They found that the TNF-levels were elevated at admission to the ICU, but the levels 
decreased similarly in survivors and non-survivors during the first 48 hours after onset of shock. 
Lactate levels of the non-survivors were higher and decreased less than the lactate levels of the 
survivors. IL-6 values were not associated with mortality. Some of the inflammatory mediators 
remain elevated for prolonged periods of time, especially if the clinical course is complicated. 
Oberhofer et al showed in sepsis patients who were treated for longer than 2 days in the ICU that 
TNF-a, IL-6 and procalcitonin levels were good predictors of death as assessed with ROC-curves 
(Oberhoffer, et al. 1999). Also C-reactive protein had a similar ROC-AUC in this study. The date 
of blood sampling was randomly chosen and every patient was presented by one sample only. The 
results of Pettilä et al studying the predictive role of procalcitonin and IL-6, among others, 
supports the finding that inflammatory markers are better predictors after some days of ICU-care. 
Procalcitonin and IL-6 values of the ICU-day 2 showed a reasonable good discriminatory power 
reflected in relatively large (>0.75) ROC-AUCs (Pettilä, et al. 2002a). Dunham et al showed that 
the mean C-reactive protein level of days 3 and 7 was correlated with the development of MOF in 
trauma patients (Dunham, et al. 1994). This study indicates that C-reactive protein is not an early 
prognostic marker of adverse outcome in trauma patients. Pettilä et al found a similar result in 
patients with suspected sepsis; admission C-reactive protein levels were similar in survivors and 
non-survivors (Pettilä, et al, 2002b). The timing of sampling of these laboratory markers is of 
importance for the outcome prediction because some of the cytokines are very short lived and the 
inflammatory markers elevate after a latency period. 
2.3.4 Lactate levels and prediction of ICU-outcome  
The role of lactate as a predictive instrument is well established. Table 2-1 summarises 
studies on the role of lactate as a predictor of ICU-outcome. The initial lactate levels, peak lactate 
levels and prolonged clearance of lactate, are all associated with complicated outcome. Already 
1965, Peretz et all demonstrated an association of lactate levels with outcome in patients with 
shock syndrome and patients unable to normalise their lactate levels had a 100% mortality (Peretz, 
et al. 1965). Elevated lactate levels are associated with increased mortality in trauma patients 
when measured at the time of initial resuscitation (Duff, et al. 1966, Blow, et al. 1999). Peak 
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lactate levels during resuscitation of trauma patients are also associated with the outcome (Vitek 
and Cowley 1971, Manikis, et al. 1995). Delayed lactate clearance after trauma is associated with 
increased probability of death and development of MOF (Abramson, et al. 1993, Manikis, et al. 
1995, Blow, et al. 1999, Claridge, et al. 2000). In shock states of different origins, lactate is a good 
prognostic tool (Vitek and Cowley 1971, Vincent, et al. 1983, Bakker, et al. 1991). Elevated 
lactate values at ICU-admission are indicators of poor outcome in patients with acute myocardial 
infarction (Henning, et al. 1982). Elevated admission lactate in patients with suspected myocardial 
infarction is highly specific in identifying patients with myocardial compromise needing closer 
attention and care (Schmiechen, et al. 1997). An earlier study by Kessler et al, showed that resting 
lactate levels after cardiac arrest were higher in patients who experienced a recurrent cardiac event 
and peak lactate levels after exercise were higher in patients dying of cardiac causes (Kessler, et 
al. 1987). More recently, Smith et al examined the role of lactate and base deficit in a rigorous 
way as prognostic tools in 148 mixed intensive care patients (Smith, et al. 2001). They determined 
a threshold value for admission lactate most closely associated with mortality arbitrarily by 
inspection of ROC-curves and came up with 1.5 mmol/L. ROC-AUC for mortality of admission 
lactate was 0.78 with a sensitivity of 69.0% and specificity of 77.3% with this cut-off value (LR+ 
3.0). Patients with admission lactate > 1.5 mmol/L had a mortality of 61.4%compared with 17.6%  
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Table 2-3. Studies of lactate as a predictor of ICU-outcome. LR+ was calculated, if possible. 
 
Author(s)  
/Year 
Number of 
patients Population 
Study 
outcome 
Threshold 
value of lactate 
or goal of 
treatment  
Compared groups or study 
design 
Pereta /1995 52 Circulatory shock Mortality  Association between lactate
 
and mortality  
Weil adn Afifi 
/1970 142
 Circulatory shock Mortality  
4.8 (determined 
by discriminant 
analysis 
Discriminant analysis 
Vitek and 
Cowly /1970 126
 Shock Mortality  NA Logistic analysis 
Henning et al 
/1982 28
 Acute myocardial 
infarction Mortality  NA 
Survivors vs. nonsurvivors at 
admission and at maximal CO 
Siegel et al 
/1990 185
 Blunt trauma  Mortality  NA Linear regression 
Bakker et a 
l/1991 48
 Septic shock Mortality  NA 
Survivors vs. nonsurvivors. 
Admission vs. 
postresuscitation 
Stacpoole at al 
/1993 126
 Patients with lactic 
acidosis Mortality  NA Survivors vs. nonsurvivors 
Abramson et 
al /1993 76
 Trauma  Mortality  Therapeutic goal
 
< 2.0 Survivors vs. nonsurvivos 
Sauaia et al 
/1994 
106 with lactate 
values Trauma  MOF 2.5 
Univar. analysis and logistic 
regression to identify 
riskfactors 
Manikis et al 
/1995 129
 Trauma  Mortality and MOF 1.5 
Association between mortality 
and lactate 
Bakker et al 
/1996 
74 surviving  
>24h, Total 87 Septic shock Mortality  NA Survivors vs. nonsurvivors 
Marecaux et 
al. / 1996 38
 Septic shock Mortality  NA Survivors vs. nonsurvivors 
Bernardin 
/1996 32
 Septic shock 10-days 
mortality 
After 24h 
treatment <3.5 Survival analysis 
Blow et al 
/1999 85
 Major trauma 
Mortality, 
MOF, resp. 
complications 
Therapeutic goal 
< 2.5 
Survivors vs. nonsurvivors 
Clearance of lactate after 6, 
12, 24 hours or later 
Claridge /2000 381 Major trauma Infection rate 2.4 at 12 hours Risk of infection 
McNelis et al. 
/2001 95
 Consecutive SICU 
patients Mortality  NA Stepwise regression analysis 
Kobayashi et 
al. /2001 22
 Consecutive patients 
with SIRS Mortality  
Second day 
lactate 2.5 
Survivors vs. nonsurvivors 
With or without DIC 
Smith et al. 
/2001 148
 Consecutive mixed 
ICU patients Mortality  
1.5 at admission 
1.0 at 24 hours 
Prognostic value of lactate at 
admission and at 24 h 
Bernal /2002 107 Paracetamol induced
 
liver failure Mortality  
Admission 3.5, 
Late 3.0 Risk of death  
Husain et al. 
/2002 137
 Surgical ICU Mortality and morbidity Normal < 2.0 
Survivors vs. nonsurvivors 
Clearance time (hours) 
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Author(s)
/Year Result (Lactate values in mmol/L) Comments
LR+ for the
outcome
Peretz /1995 Stepwise increase of mortality with increasing lactatelevels
Weil and
Afifi /1970
Correct classification rate 88% with a reference value
of 4.2
Vitek and
Cowly /1970
Stepwise increase of mortality with increasing lactate
levels
SL50  4.9, Time-point of blood
sampling not reported
Henning et
al /1982
Admission lactate 3.5 vs. 4.3(p<0.05), at highest CO
2.5 vs. 4.7(p<0.01), 4 h before discharge 1.9 vs.
8.8(p<0.01)
Siegel et al
/1990
P < 0.0001 LD50  9.5
Bakker et a
l/1991
Early: surv/nonsurv. 5.1/8.2(p<0.05), Late
surv/nonsurv. 2.6/7.3(p<0.001)
Admission values 1 4 hours,
Postresusc. Values when SAP >90
without inotropes or before death
Stacpoole at
al /1993
Mean lactate: surv/nonsurv. 9.2±4.9/12.2±5.9
(p=0.004)
Lactate not significant after controlling
for APACHE II, SAP and arterial pH
Abramson et
al /1993
Initially no difference, Lactate elevated for < 24h,
mortality 0%, for 24-48h, mortality 22.2%, for >48h,
mortality 86.4% (p<0.0001)
Lactate measured at 8 h intervals for
48 hours
Sauaia et al
/1994
Lactate at 12 to 24 hours after admission an
independent predictor of MOF, OR 5.9(1.92-12.35, p
=0.0012)
Manikis et al
/1995
Initial lactate surv/nonsurv 2.8/4.0 (p<0.05), maximal
lactate lactate surv/nonsurv 3.4/4.6 (p<0.05). Initial
lactate MOF/no-MOF: 3.4/2.4 (p<0.01)
Lactate measured at least 2 times/day
until normal. Lactime (Number of days
with lactate > 1.5 determined)
Bakker et al
/1996
Initial lactate: no difference. Lactime(= hours with
lactate >2.0)  and AUC of lactime curve higher in
nonsurvivors
Additional 13 patients died in the first
24 hours and were excluded. Curve
constructed with two values assuming
linear trend
Marecaux et
al. / 1996 Lactate higher in nonsurvivors (p<0.05) No difference in TN-
a and IL.-6
Bernardin
/1996
If 24h lactate >3.5: mortality 80.8%, if < 3.5: mortality
30.7% (p=0.0019). Surv/nonsurv at 24h: 2.4±1.4/
5.7±3.9(p>0.05)
Lactate cut-off 3.5 at 24hours. MAP at
24h < 85mmHg associated with
increased mortality
Blow et al
/1999
Mortality 43 vs 0%, MOF 64 vs 5%, respiratory
complications 50 vs 15% if lactate clearance < or > 24
hours
Lactate measured at 6 hours intervals
Claridge
/2000
OR for infection if lactate elevated > 12 hours 5.33 (CI
3.07-9.26)
Correction of lactate(<2.4) at 12, 24
hours or later. Population mortality
low (3.3%)
McNelis et
al. /2001
Initial lactate surv/nonsurv 4.3±2.1/7.3±5.4 (p<0.01).
Time to lactate clearance surv/nonsurv
17.0±22.2/48.0±30 hours(p<0.0001)
Initial lactate not significant for
mortality, if lactate clearance included
Kobayashi et
al. /2001
Admission and first day lactate no difference.  2
nd
 and
4
th
 day lactate higher in nonsurvivors Lactate values every 4 hours for 4 days
Smith et al.
/2001
Admission lactate: ROC-AUC 0.78, Sensitivity
69.0%, Specificity 77.3%. If admission lactate >1.5
and 24-hours lactate >1.0, mortality 81.5% compare to
23.8% if 24-hours lactate < 1.0
Threshold values determined from the
ROC curves
Adm lactate >1.5: 3.0
Adm lactate >1.5 and
24h lact > 1,
compared to adm
lactate < 1.5 and 24h
lactate < 1.0, LR+
9.4.
Bernal /2002
Early lactate >3.5: OR 43(9.1-201, p <0.0001), Sens
67%, Spec 95%. Postresuscitation lactate >3: OR
63(10.4-385, p<0.0001). Sens 76%, Spec 97%
Early = first 4 hours, Postresuscitation
12 hours after admission
Early LR+ 13,
Postresuscitation
LR? 30.
Husain et al.
/2002
Initial lactate surv/nonsurv 2.8/4.2(p=0.002), 24-h
lactate 2.2/5.1(p<0.001). Mortality if lactate clearance
in 24 h 10%, in 48h 20%, in >48h 23%, never 67%.
Independent predictor of death: 24h lactate
Retrospective analysis. Initial lactate
higher and clearance time longer in
patients with complicated outcome.
Lactate not predictive in major
abdominal surgery patients.
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in patients with lower lactate (p <0.05). The mortality of patients with admission lactate over 1.5 
mmol/L and with the 24 hours lactate above 1.0 mmol/L was 81.5% compared with 23.8% 
(p<0.05) if the lactate after 24 hours was less than 1.0 mmol/l (LR+ 3.4). Both these cut-off values 
are lower than in previous reports. Differences of case-mix might have resulted in these lower 
threshold values with fewer patients after trauma or hemorrhagic shock of other etiologies which 
can easily be corrected by fluid resuscitation. A similar study was done by Husain et al, who 
showed in surgical ICU-patients that initial and 24-hour lactate levels were higher in non-
survivors than in survivors (Husain, et al. 2003). Lactate clearance in 24 hours was associated 
with 10% mortality compared to 24% if lactate normalised in more than 48 hours and to 67% if 
lactate failed to normalise.  
Despite the fact that lactate elevation can arrive through several pathways, the clearance of 
lactate after circulatory failure can be considered as a sign of success of resuscitation. A number 
of reports show that prolonged elevation of lactate levels is highly correlated with mortality and 
development of MOF or ARDS (Vincent, et al. 1983, Pasch, et al. 1987, Moore, et al. 1992, 
Roumen, et al. 1993, Manikis, et al. 1995, Bakker, et al. 1996). A prolongation of lactate 
clearance for longer than 12 hours in trauma patients and longer than 48 hours in septic shock 
predisposes the patients to the development of MOF (Tuchschmidt, et al. 1989, Sauaia, et al. 
1996), whereas lactate normalisation in 24 hours practically leads to a 100% survival rate 
(Abramson, et al. 1993). The duration of lactate elevation is a better predictor of outcome than 
peak lactate values (Bakker, et al. 1996). Lactate clearance is also associated with the use of ICU-
resources. McNelis et al found a 100% mortality rate among surgical ICU patients who were 
unable to normalise their lactate values in 98 hours (McNelis, et al. 2001). One third of the non-
survivors spent more than 50 days in the ICU.  
The presence and duration of metabolic acidosis with elevated base deficit without 
concomitant hyperlactatemia has been shown to be associated with adverse outcome as well. This 
is to be expected because hyperlactatemia and development of acidosis are both related to 
impaired tissue oxygenation though not to same biochemical processes. Prolonged metabolic 
acidosis after resuscitation of trauma patients with normal lactate levels is associated with 
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increased mortality and incidence of MOF (Kincaid, et al. 1998) and ARDS (Eberhard, et al. 
2000). Elevated base deficit has been identified as an early indicator of hemodynamic instability 
and it is associated with the need of blood transfusions and with high probability of death in 
trauma patients (Rixen, et al. 2001). The study of Smith et al has shown that the admission base 
deficit has a ROC-AUC of 0.73 for mortality in mixed ICU-patients (Smith, et al 2001). The same 
groups found a critical cut-off level for admission base deficit of 4 mmol/L and for the 24-hours 
base deficit of 2.5mmol/L. These points were close to the upper left corner of the ROC-curve. The 
admission cut-off value had a sensitivity of 70.6% and a specificity of 72.2 in predicting death 
(LR+ 2.5). If the patients with the admission base deficit of more than 4 mmol/L could not clear 
their acidosis to a level less than 2.5 mmol/L, the mortality was 70.6% in contrast to 11.1% 
(p<0.05) in patients who could clear the acidosis in 24 hours (LR+ 2.4). In the study of Husain et 
al, initial base deficit was not different between survivors and non-survivors but there was a 
difference in base deficit after 24-hours (Husain et al. 2003). 
The main reason for using base deficit instead of lactate is the better availability of blood gas 
measurements compared to lactate. Though some studies have proposed that base deficit should 
be used as a prognostic marker instead of lactate after injury (Siegel, et al. 1990, Kincaid, et al. 
1998), lactate is more closely associated with different aspects of acute illness through its several 
pathways of production. Lactate level cannot be predicted with acid base status (Mikulaschek, et 
al. 1996, Husain, et al 2003).  
Early studies indicated that the L/P-ratio was normal, if it was below 10 to 15:1. (Huckabee 
1958a). Predictive use of L/P-ratio was estimated already in early studies, which found the 
addition of L/P-ratio not to improve the predictive power of lactate (Weil and Afifi 1970). The 
most critical practical point concerning the use of L/P-ratio in the clinical setting is the need for 
cautious handling of the pyruvate sample (Chariot, et al. 1994). The pyruvate samples have to be 
deproteinised and deep frozen very quickly. It seems that L/P-ratio elevations in circulatory failure 
occur simultaneously with lactic acidosis (Levy, et al. 2000) but how this contributes to its 
predictive use is not well understood. 
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2.3.5 Confounding factors in the interpretation of lactate and L/P-ratio values. 
Sympathomimetic substances, either endogenously or exogenously, affect lactate and 
pyruvate metabolism. In healthy volunteers during exercise the epinephrine levels correlate with 
the levels of lactate and L/P-ratio (Wasserman, et al. 1985). An epinephrine infusion increases the 
levels of lactate and L/P-ratio in a similar fashion but the increase of lactate is relatively greater 
than the increase of pyruvate (Levy, et al. 1997). The pyruvate declines more slowly than lactate 
during the recovery phase after an exercise. In sepsis patients, endogenous epinephrine levels are 
related to the elevations of lactate (James, et al. 1999). However, epinephrine infusion during 
septic shock might be responsible for impaired splanchnic oxygen transport (Levy, et al. 1997, 
Meier-Hellmann, et al. 1997) indicating that lactate elevations of septic patients caused by 
epinephrine are not simply related to its metabolic action. Respiratory alkalosis elevates the lactate 
levels by interfering with the clearance of lactate (Goldstein, et al. 1972, Druml, et al. 1991) and 
lactate release from the splanchnic region (Karlsson, et al. 1995). Lactate elimination occurs 
mainly in the liver and acute liver failure is associated with lactate elevation also without 
circulatory impairment. Lactate elevation in patients with acute liver failure caused by 
paracetamol is an accurate predictor of death (Bernal, et al. 2002). The retrospective study by 
DeJonghe et al showed that patients with early (during the first 48 hours) hepatic dysfunction 
induced by circulatory failure had higher lactate levels. Independent predictors of serum lactate 
where hepatic dysfunction, non-distributive type of shock and use of epinephrine (De Jonghe, et 
al. 1999). Ethanol ingestion interferes with the metabolism of carbohydrates (Goldfrank and 
Starke 1991) and moderate levels of hyperlactatemia have been found in patients with acute 
alcohol intoxication (Fulop, et al. 1986). From the clinical point of view, it is important that other 
causes than alcohol consumption are to be sought for as the cause of lactate elevation also in 
intoxicated patients (MacDonald, et al. 1994). Ethanol ingestion induces an inhibition of the 
gluconeogenesis from pyruvate resulting in markedly elevated L/P-ratio values (Lecky, et al. 
2002). This interference hampers the use of L/P-ratio as a predictor of outcome in this patient 
category. 
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2.4 Outcome prediction using severity scores 
2.4.1 General aspects  
Prediction of ICU and hospital outcome has the aim to estimate patients’ outcome based on 
the available data. Aside of the present diagnosis, patients have a history of chronic illnesses 
influencing their abilities to survive. Furthermore, outcome is affected by the severity of the 
present illness and quality of care. The patients whose therapy has been withdrawn with 
subsequent fatal outcome are difficult to handle in outcome prediction studies and occasionally 
DNR patients were eliminated from study population (Knaus, et al. 1985b). If treatment has been 
continued up to time point of withdrawal, DNR patients should not be excluded. Similar problems 
may arise with cases not receiving full-scale treatment. Outcome of intensive care is most often 
reported as ICU mortality, hospital mortality or mortality on a specified day. Intensive care 
mortality can be strongly biased through different treatment policies of hospitals and practices to 
handle patients with poor prognosis vary considerably. Hospital outcome is considered to be less 
affected by bias, although many patients are discharged from hospital to other institutions for 
rehabilitation or continued care. In these cases the final outcome of the patients might remain 
unknown or the transferred patients are considered as survivors, because they leave the hospital in 
question alive. Also patient transferrals to other intensive care facilities take place. Most often, 
outcome prediction is related to the mortality during the same hospitalisation period or status at 
hospital discharge but it could be related also to the length of stay in the ICU or in hospital (Barie, 
et al. 1996b, Woods, et al. 2000), the qua lity of life (Buist 1994)) and costs (Zimmerman, et al. 
1995). An optimal prediction instrument should be easily obtainable and objective (Kollef and 
Schuster 1994). The latter property implies that every person performing the data collection finds 
the same value. This is true for variables which do not include subjective assessment. Some 
variables are subjective in their nature. E.g. urine output in 24 hours is an objective value, but 
grading of somnolence or agitation is not. The prediction instruments should be applicable in 
many patient categories i.e. they should not be specific for one group of patients only. The 
differences of health care systems between countries and continents make uniform and bias-free 
systems nearly impossible. Because of variability in patient population and in ICU-and healthcare 
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environment the prediction models can be used only in the surroundings where they were 
developed. Each model should be recalibrated before being used in a new population (Kollef and 
Schuster 1994, Moreno and Apolone 1997, Moreno, et al. 1998). 
2.4.2 The APACHE and SAPS systems  
The first generation severity score, acute physiologic and chronic health evaluation, 
APACHE, was introduced in 1981 (Knaus, et al. 1981). The main aim was to introduce a method 
for describing severity of illness for groups of patients. APACHE consisted of 34 physiological 
variables and a four step grading for the severity of the chronic disease. The selection of the 
physiological variables and the weights of them ranging from 0 to 4 were determined by a small 
group of experts. The observation period for finding the worst value was 32 hours because it 
included 4 working shifts. It was primarily tested in 582 admissions and a clear correlation 
between APACHE-score and mortality could be detected. Only patients staying longer than 24 
hours in the ICU were included. An analysis of APACHE system was published a year later 
(Knaus, et al. 1982). The risk coefficients were calculated using data of 613 patients originating 
from one hospital and the predictive performance was tested in 795 patients from 5 other 
hospitals. There was a good correlation between acute physiological score of APACHE and 
mortality. APACHE proved to be a good predictor of outcome in many disease categories 
(Wagner, et al. 1983). The APACHE system included also arterial lactate concentration with a 
normal range (giving zero points) below 3.4 mmol/L. 
APACHE II was introduced 1985 and was intended to be clinically more useful, simpler and 
still accurate enough for patient classification (Knaus, et al. 1985a). The data of 5815 patients 
from 13 hospitals were collected. The set of variables for the acute physiologic score (APS) were 
reduced to 12 and the staging from 0 to 4 points was used as in the APACHE system. Lactate was 
omitted because, as it was noted, it was not routinely measured. For age and chronic health status 
points were assigned. Accordingly, the APACHE II sum consisted of APS, chronic health points 
and age points. The admission diagnosis was included into the risk calculation in form of a 
weight. Twenty-nine non-operative and 16 operative diagnoses were given weights and if not 
available, one of 5 main vital organ systems responsible for the admission, should be selected. 
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Emergency operative status was given a special coefficient. APACHE II model had a correct 
classification rate of 85.5% with a specificity of 94.9% and a sensitivity of 47.0%, (Knaus, et al. 
1985a). The association of APS with outcome is depending on the diagnostic group and in patients 
with pulmonary embolism and diabetic ketoacidosis the association is poor (Wagner, et al. 1986). 
Apache III is the latest development in the field of severity scores (Knaus, et al. 1991). 
Unfortunately, the logistic regression coefficients and details of the weights of disease categories 
are private property and thus not freely available. This has limited the acceptance and utilisation 
of this system considerably. Apache III has corrected some of the limitations in the Apache II 
system. It consists of acute physiological score with 17 variables, of age-points, of 7 comorbid 
conditions and of score for the location prior to ICU-admission. The acid-base status incorporates 
pH and carbon dioxide levels. In the scoring of neurological abnormality, instead of the GCS, a 
special scheme of the neurological evaluation has to be used. For the calculation of the probability 
of death one of the 78 disease categories is selected. The performance of the Apache III system 
was excellent with a ROC-AUC of 0.9 and correct classification rate of 88.2% in a database of 
17440 admissions (Knaus, et al. 1991). 
Le Gall et al. constructed a simplified version of scoring (simplified acute physiology score) 
which was based on the first APACHE system (Le Gall, et al. 1984). Instead of 34 variables, 
SAPS contained 14 variables and the weights were similar to those in APACHE. SAPS was not 
extensively used, because it was published only 1 year before APACHE II which became the 
preferred instrument for several years. One additional negative feature of SAPS was that it was 
not convertible to a probability of mortality. 
The new version of SAPS, the SAPS II was based on a large European – North American 
population of 13152 patients (Le Gall, et al. 1993). A statistical modelling was used for defining 
the weights of the variables. Only 3 diagnostic categories, metastatic cancer, hematological 
malignancy and AIDS as well as 3 types of admissions, scheduled surgical, unscheduled surgical 
and medical, were included and they were incorporated to the scoring system. The sum score 
could be transformed to a probability of hospital death using a logistic regression formula and the 
model contained an extra variable, ln(SAPS +1), for correction of the skewed distribution of 
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SAPS II scores. The weights of the included variables were calculated through statistical 
procedures and in all cases each variable was represented by one “worst” value. 
A third prediction model, the mortality probability model or MPM was based on statistical 
analyses of a large series of variables associa ted with the outcome (Lemeshow, et al. 1985). The 
main goal of the process was to build a prediction model for mortality, not a measure of severity 
of illness. The second version, the MPM II was based on the same database as the SAPS II 
complemented with data of six ICUs in the USA (Lemeshow, et al. 1993). In a further 
developmental step the same group implemented data collected at 24-hour intervals after 
admission and developed the MPM24 and MPM72 models (Lemeshow, et al. 1994). In the MPM 
model patient status is estimated dichotomously as a presence or absence of a variable like coma, 
infection, vasoactive medication, mechanical ventilation, heart rate above and blood pressure 
below a threshold value etc. Only age is a continuous variable. This review will focus on the 
SAPS II and APACHE II scoring systems, because they are commonly used and they can be used 
to describe the SIRS and circulatory failure in a more detailed form. 
2.4.3 Calculation of the probability of death 
The association between probability of death and with the severity score is not linear. The 
severity score is transformed to a logit following principles of logistic regression analysis. The 
equation of logit is of the form (Le Gall, et al. 1993): 
Logit = b0 + b1x severity score + b2 x dependent variable 1 + b3 x dependent variable 2 . 
In this formula b0 is a constant, and dependent variables are weights of admission diagnosis, 
emergency operative status and for the SAPS equation the variable ln(SAPS +1). This was 
included into the equation to correct the skewed distribution of the SAPS II scores. (Le Gall, et al. 
1993). The logit is converted to a probability of death using the formula: 
 Probability = e logit/1+elogit.  
From this equation follows that the probability of death is a S-shaped curve and the nearly 
linear mid-section of the curve lies at the probability of death of 0.5. Because the admission 
diagnosis is separately included into the APACHE II prediction equation, a whole spectrum of 
curves is produced, the location of which on the x-axis determines the association between risk of 
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death and APACHE II score. The prediction of survival or non-survival in 2x2 tables is done at 
the decision point 0.5 of risk which means that one point increase in severity score at this point 
might shift the patient from those predicted to survive to those predicted to die.  
2.4.4 Calculation of the performance of prediction models  
The two cornerstones in estimating the performance of predictive tools is to have a measure 
of discrimination and a measure of calibration. Discrimination is the ability of the prediction 
instrument to correctly identify survivors and non-survivors. This is done by constructing a 
diagram combining sensitivity and specificity, the receiver operating characteristic curve, ROC-
curve (Figure 2-1) and by calculating the area under the ROC-curve, ROC-AUC (Hanley and 
McNeil1982).  
 
 
FIGURE 2-1 The ROC-curve combines the sensitivity and specificity of an outcome variable to 
one graph. The area under the curve, the ROC-AUC of this curve is 0.839 (SE 0.831-0.848) 
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The closer the ROC-AUC is to 1.0 the better is the discrimination. ROC-AUC of 0.5 means a 
discriminatory performance equal to pure chance or tossing a coin. If the ROC-AUC is above 0.8, 
the discriminator is considered excellent (Le Gall, et al. 1993). The second objective, the 
calibration means that the prediction instrument performs well over the whole range of risk. For 
this purpose, the goodness-of-fit procedure has been used with calculation of applied chi-square 
statistics as proposed by Hosmer and Lemeshow (Lemeshow and Hosmer1982, Hosmer and 
Lemeshow1989). To do this the population is divided into 10 strata of increasing risk, either in 
equally sized groups or in deciles of increasing risk of death. The former gives the C* statistics 
and the latter the H* statistics when the chi-square values of each strata are summed. H* statistics 
is the mathematical expression for the calibration curve as it is drawn after division of the 
population into deciles of increasing probability of death on x-axis and observed mortality of each 
strata on y-axis. The expected mortality is compared to the observed one over the whole range of 
risk. The better the calibration the lower the H* respectively C* value. If the fit of the calibration 
curve is good, it is not statistically different from an ideal line with a p-value >0.05. Recalibration 
or customisation can be done by development of a new equation for outcome prediction using 
logistic regression analysis and including all the independent variables contained in the original 
model. This is termed as second level customisation. First level customisation includes 
development of a new model with the original logit as the independent variable (Zhu, et al. 1996). 
2.4.5 Limitations and problems in severity scores in outcome prediction 
2.4.5.1 Finding the correct values for the variables and the rate of sampling 
The concept of severity scoring in the prediction of outcome includes the assumption that the 
severity of illness on the initial phase of ICU care is an important determinant of mortality 
(Knaus, et al. 1985c, Wagner, et al. 1986, Wong, et al. 1995). The association of hospital 
mortality and severity of acute illness seems to be well documented for general ICU populations 
(Le Gall, et al. 1993, Rowan, et al. 1994, Beck, et al. 1997) and also for other critically ill patients 
like patients in intermediate care and coronary care units (Schuster, et al. 1997, Auriant, et al. 
1998), and patients with myocardial infarction (Ludwigs and Hulting 1995). The association of 
the severity of acute illness and outcome is not necessarily straightforward. As described with 
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lactate, the highest value, which is very often the first value as well, might not always be the value 
most strongly related to the outcome. The clearance of lactate, which is reflected in the last value 
of the initial 24 hours, is more clearly associated with mortality than the highest value per se 
(Vincent, et al. 1983, Abramson, et al. 1993, Bakker, et al. 1996, Bernardin, et al. 1996). Only the 
variables in the MPM models have been tested statistically in relation to mortality. Theoretically, 
the change of values in time, in contrast to worst values, e.g. of pH, pO2 and base excess could 
reflect a unsuccessful resuscitation (Kincaid, et al. 1998) and thus be more closely associated with 
mortality than the worst values. The effect of treatment is not included in the severity scores 
(Cowen and Kelley 1994). The effect of treatment can to some extent be studied by measuring 
severity scores repeatedly. Increased severity of illness is associated with high mortality (Bion, et 
al. 1988, Chang, et al. 1988). However, a subsequent study with the same approach in a larger 
database was not able to repeat the good result of the previous study (Rogers and Fuller 1994). 
Using severity scores repeatedly has never been validated and is very much subject to bias caused 
by therapeutic measures. The approach of repeated measurement of risk has been included into the 
APACHE III system (Knaus, et al. 1991). Because most often the worst values are the first ones, 
repeated measurement does not bring in new information (Knaus, et al. 1985a). In contrast to the 
severity scores, the impact of treatment is included in the SOFA-scores in the form of vasoactive 
medication (Vincent, et al. 1996). The authors of the APACHE II indicate in their original 
publication that an as early as possible time point would be the best for scoring e.g. the emergency 
department in order to eliminate the effect of treatment to the scores (Knaus, et al. 1985a). Some 
more confusion arrives to this issue in the technical protocol of the APACHE III data collection 
(Knaus, et al. 1991). According to the protocol, admission values were those taken during the 
initial 1 hour of ICU stay. If there were no values available the previous, pre-ICU 1 hour time 
period was used. The worst value of the first day was either an admission value or the value taken 
during the next 23 hours. Whether this approach was used also during the collection for APACHE 
II, has not been clarified in the literature (Rowan 1996). 
Route of admission or the location of the patient prior to admission to ICU is included in the 
APACHE III scoring system. Preliminary studies have shown that the location from which the 
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patient is transferred to the ICU is related to the outcome (Dragsted, et al. 1989, Escarce and 
Kelley 1990). Escarce could clearly show that patients transferred from hospital areas, where they 
could be stabilised for a longer period of time, had higher than expected mortality (Escarce and 
Kelley 1990). This finding emphasises the fact that if patients can be stabilised prior to admission, 
the severity scores are low and the expected death rate as well. The mortality of patients in the 
study by Escarce transferred directly from the emergency department was close to the predicted 
mortality. The impact of early resuscitation on severity scores is also reflected in the study by 
Rivers et al who used a goal directed therapy for septic shock patients required to wait about 6 
hours to be admitted to the ICU (Rivers, et al. 2001). Aside of lactate values, also the APACHE II 
and SAPS II scores of the treatment group were lower than of the control group. 
The application of computer technology for automated data collection has increased the 
sampling rate considerably and omitted the need of professional personnel to interpret and record 
the clinical data. All continuous variables can be measured with high resolution, which 
necessitates also the use of different techniques to solve the problem of artefact recognition 
(Sukuvaara, et al. 1993). The high resolution of collected data of continuous variables results in 
higher scores because abnormal values are found more often (Bosman, et al. 1998). The clinical 
significance of the recorded alterations is not considered. There are no commonly accepted 
agreements of the duration of an alteration to be included into the severity scores (Marik and 
Varon 1999). 
The relative contribution of the predictor variables to the risk estimation varies from variable 
to variable and is dependent on the patient group for which the risk is estimated. Among the risk 
predictors, the Glasgow Coma Scale (GCS) has a very unique role. In trauma patients, 75% of the 
predictive power of APACHE II system is explained by the GCS alone (Vassar, et al. 1992). In 
cardiac arrest patients, the GCS alone is as good a predictor of hospital outcome as APACHE II 
score (Niskanen, et al. 1991). The non-linear fashion of the weights of the scores and lack of 
consistency in the relative importance of different variables in relation to outcome interfere with 
the mathematical calculation of the risk of death. E.g. core temperature change in APACHE II 
scoring with an increase by one step from 1 to 2 points bears not the same increase of risk of 
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hospital death as the rise by one step from 3 to 4. Similarly, two points of the score in GCS are 
most likely not similarly related to mortality as two points resulting from serum sodium or age of 
45 years. 
Some studies have compared the ability of the care personnel, physicians and nurses, with 
prediction models to predict hospital outcome. If the data collection for both, the clinical and 
APACHE II assessment were performed simultaneously and shortly after admission, the ability 
for correct prediction was identical (Kruse, et al. 1988). If the physicians had information of the 
whole first day, the clinical prediction was better than the APACHE II system (Brannen, et al. 
1989). This difference can partly be explained by the knowledge of the response to treatment, 
which made the prediction in the latter study more exact.  
2.4.5.2 Case mix 
The development and validation populations determine the case-mix which the model is 
designed for. Case-mix differences can be very obvious, like patients in specialised units designed 
for subgroups of patients like surgical (Meyer, et al. 1992), cardiac (Schuster, et al. 1997), trauma 
(McAnena, et al. 1992, Roumen, et al. 1993), respiratory (Del Bufalo, et al. 1995) and neurologic 
(Weingarten, et al. 1990). If the mortality rate of the study population is far different from the 
original one, this is also a case-mix difference and the model does not perform well unless it is 
customised for the new population (Zhu, et al. 1996). As the time of death is far apart from ICU-
admission or patients are treated for prolonged time in the ICU, the prediction models are not 
accurate (Sleigh, et al. 1992, Sicignano, et al. 1996). Sleigh et al studied 383 patients in two ICUs 
and measured APACHE II scores on the first ICU-day. Thirty-five % of patients stayed in the ICU 
one day or less. Patients treated shorter than for 4 to 5 days were in more than 80% of cases 
correctly classified to die. In contrast, in patients with an ICU-LOS of 6 days or more, correct 
classification rate fell to 62%. Sicignano et al used the first generation SAPS-score in a group of 
8059 patients. Patients with an ICU-LOS of less than 24 hours were excluded. The investigators 
developed a prediction model for SAPS. ROC-curves were constructed for patient groups with 
increasing ICU-LOS. The ROC-AUC for the whole population was 0.79. The group with ICU-
LOS longer than 4 days had a ROC-AUC less than 0.7 and the group with ICU-LOS longer than 7 
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days a ROC-AUC round 0.66, which indicates that the discriminative power was lost as the ICU-
LOS prolonged.  
Patients treated longer than 24 hours only were included into the original APACHE score, 
but the APACHE III included all patients treated longer than 4 hours as mentioned earlier. If a 
large proportion of dying patients is treated a very short time e.g. less than 2 days, the prediction 
models will focus on the risk of death of this group. Only few studies have given detailed 
information on the distribution of ICU-LOS (Meyer, et al. 1992, Barie, et al. 1996b, Wong, et al. 
1999). In the study of Barie, 57% of patients stayed less than 3 days and in the study of Wong, 
60% of patients stayed less or equal to 2 days showing that majority of patients are treated for 
short time only. The costs of intensive care are associated with prolonged stay and development of 
MOF (Oye and Bellamy 1991, Barie and Hydo 1996). In the study of Oye et al, outcome 
prediction using the APACHE II model for high cost patients, predicted death for 43.4% of 
patients whereas the observed mortality was 70.6%. High cost patients consumed 50% of total 
ICU resources but consisted of only 8% of the total number of patients. The predicted and 
observed mortality rates of the low-cost patients were 24.6% and 20.0%, respectively. The 
prediction of the outcome of the high-consumers of ICU resources with prolonged stay is less 
accurate than of those receiving only a short period of treatment. 
It is evident from the early studies on that aside from the severity of acute illness, also the 
admission diagnosis is important for the prognosis (Knaus, et al. 1985c). A certain severity of 
illness measured with severity score in one diagnostic group is not associated with the same risk 
of death in some other diagnostic group. Typically, patients with intoxication have a lower risk of 
death than patients with GI perforation with the same severity score. Elective surgical admissions 
bear a lower risk of death than emergency surgical admissions and medical admissions (Knaus, et 
al. 1985a, Cerra, et al. 1990). Elective admissions are selected and planned and patients can be 
prepared for the surgery and ICU admission, which ultimately should be accompanied by lower 
risk compared to emergency admissions. In some diagnostic groups of APACHE II, like diabetic 
ketoacidosis, pulmonary embolism and respiratory arrest patients, there is no relationship between 
severity of illness and mortality (Wagner, et al. 1986). In these diagnostic categories the mortality 
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prediction based on severity scores is misleading because it is depending on the admission 
diagnosis only. For APACHE III, in patients with pneumonia, subarachnoid hemorrhage and acute 
myocardial infarction or unstable angina the predicted death rate was higher than the observed 
mortality. In patients with cardiac arrest, sepsis of urinary tract origin, head trauma, multiple 
trauma, GI bleeding and especially with drug overdose, the observed death rate was higher than 
the predicted one (Zimmerman, et al. 1998). The weights of diagnostic groups in the original 
publication of Apache II have not been questioned over the years although the risk of death 
associated with each diagnostic group might have changed over the years. As is evident from the 
previous citation, also the weights of diagnostic categories in APACHE III might not be accurate. 
The APACHE-systems have been criticised for the difficulty of selecting the only one admission 
diagnosis because the relative importance of several possible admission diagnoses is often not 
obvious (Vassar and Holcroft 1994). 
2.4.5.3 Lead time bias  
Lead time bias is a term normally associated with the results of cancer treatment. Lead-time 
bias is present when e.g. an improvement of diagnostic capabilities results in an earlier detection 
of patients with cancer and an earlier start of medication and care. When the survival time is 
calculated from time of diagnosis to death, it looks as if the survival time has increased, when it 
actually has remained the same; only the diagnosis is done earlier. This approach transferred to the 
ICU surrounding would mean that the predicted risk is dependent on the time when it is 
determined. Pre-ICU treatment and location of the patient before ICU admission were already 
discussed above. It is much more difficult to assess the timing of the resuscitative efforts in 
relation to the disease process as a whole. As discussed earlier, resuscitation of trauma patients 
and association of trauma-resuscitation with MOF and mortality is easier to study because the 
time-relations are precise (Shoemaker 1996). The exact timing of a community acquired 
pneumonia with sepsis or SIRS is much more difficult to assess. Delays before contacting medical 
personnel and delays in the hospital until admission to ICU for care and making the risk prediction 
are often obscure. 
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All of the scoring systems assume that data for scoring is collected solely during the ICU 
stay with the exceptions mentioned above. The timing of scoring is one of the crucial points. The 
effect of lead-time bias on the severity scores by inclusion of pre-ICU values to the set of 
variables was studied by Tunnell et al (Tunnell, et al. 1998). They included data 2 hours prior to 
ICU-admission for vital signs and 6 hours prior to admission for laboratory data to the scores and 
found significant increases in the scores of APACHE II, APACHE III and SAPS II as well as for 
predicted mortality. The risk estimates are not correct for patients who have been treated 
effectively prior to admission if the pre-admission treatment does not lower the risk equally. The 
pre-admission values e.g. of laboratory tests should be included into the data set because these 
values often confirm the indication for the ICU-admission and to initiate resuscitation efforts and 
are not repeated before treatment is started. It is clear that treatment immediately before ICU 
admission, either by the ICU staff or others, lowers the severity of illness if only data obtained in 
the ICU is included (Rowan1998). The same applies to patients transferred from other hospitals, 
especially if they have received effective treatment in the referring hospital or during the 
transportation (Uusaro, et al. 2002) Effective treatment in the emergency department results in 
better stabilisation of patients and lowering severity scores (Dragsted, et al. 1989, Rivers, et al. 
2001). If the real risk remains unchanged but the timing of data collection results in lower scores, 
lead-time bias is present. 
2.4.5.4 Variability in data collection 
The collection of data for the severity scores is mainly accomplished by transferring data 
from medical records to databases. If the data transfer is reliable the collected data reflects the true 
variance of the sample (Damiano, et al. 1992). Damiano et al found that the reproducibility of data 
collection for APS and age is good but less good for chronic health points. In this study the 
collected data were reassessed by an data abstractor of APACHE Medical Systems. In multicenter 
studies ambiguities of definitions and problems of translation and conversion to other units than in 
the original system has been identified as a source of bias (Fery-Lemonnier, et al. 1995, Chen, et 
al 1999). Inter-observer variability can be improved by strict guidelines and training (Polderman, 
et al. 2001a). Polderman et al found that the intra-observer variability is 15% for APACHE II 
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scores and concluded that this amount of variability is inherent to the scores (Polderman, et al. 
2001b). This was studied in a set-up where the same persons collected data at intervals from the 
same records.  
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3 AIMS OF THE STUDY 
The purpose of this study was to investigate factors associated with the acute circulatory 
failure and the outcome of acute circulatory failure in terms of multiple organ failure and hospital 
outcome. Circulatory failure was studied with special reference to its indicators, lactate and 
metabolic acidosis, and its association with the development of multiple organ failure. The 
commonly used severity scores lack precise definition of the sampling method and therefore the 
impact of sampling rate on the scores was assessed. Because the patients with multiple organ 
failure stay in intensive care for a prolonged time and consume high amounts of resources, the 
accurate prediction of outcome of this patient group is of major importance. Hence, the impact of 
length of stay in intensive care on the performance of the severity scores was investigated in a 
large national database. 
The specific aims of this study were to answer the following questions: 
· What is the role of lactate, L/P-ratio and lactic acidosis as signs of circulatory failure in the 
first ICU day? 
· Is the clearance of lactate and/or metabolic acidosis associated with differences in 
hemodynamic profiles of patients in the first day of ICU-care? 
· What are the consequences of resuscitation success in terms of development of multiple organ 
failure and mortality? 
· What is the magnitude of bias caused by increased sampling rate on the APACHE II and 
SAPS II scores? 
· Are recalibrated outcome prediction models based on APACHE II and SAPS II scores reliable 
for patients in prolonged ICU care? 
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4 MATERIAL AND METHODS 
4.1 Study subjects  
The time-pattern of lactate and L/P-ratio (Study I) was studied in 98 consecutive emergency 
admission patients above the age of 16 with a mean age of 54 ± 2. Sixty-five (66%) of them were 
men. A subgroup of sixty-nine of these patients formed the study population for study III.  
The consequences of early resuscitation on the eventual development of MOF and survival 
(Study II) was studied by reconstructing the patient records of 83 patients using the CIMS 
(clinical information management system) of the ICU in Kuopio University Hospital (Clinisoft, 
Instrumentarium Helsinki Finland) and by retrieving data from written patient records. The study 
population was selected from emergent admitted patients above the age of 15 who were monitored 
invasively during the first ICU day and who stayed in the ICU for longer than 24 hours. The 
records of all patients admitted between 1st of August 1998 and 31th July 1999 were checked in 
order to identify candidates for the study. Open heart surgery patients, neurosurgical patients, 
intoxication patients and patients who were transferred from other hospitals after having received 
intensive care for longer than 12 hours before transportation were excluded. Patients with multiple 
admissions were analysed only once and if more than one admission fulfilled the inclusion 
criteria, the latest admission was selected. Only patients with a circulatory failure defined as 
arterial lactate > 2 mmol/L and/or base deficit > 4 mmol/L at any point during the first ICU-day 
were selected. From 210 candidates 83 fulfilled all the inclusion criteria and formed the study 
population. 
The effect of sampling rate to the APACHE II and SAPS II scores (Study III) was studied in 
69 consecutive emergency admission patients above the age of 16 years. The group sampled had a 
mean age of 54 ± 2 and a 42 over 27 male to female ratio.  
The effect of prolonged ICU-LOS (Study IV) on the predictive performance of APACHE II 
and SAPS II scores was studied in a prospectively collected database consisting of 23953 
admissions in 13 ICUs in non-university hospitals in Finland. The database was collected by The 
Finnish Consortium of Intensive Care Data with the aim to compare ICU performance and quality 
of care in Finnish ICUs. The database was collected during the years 1994 to 1999.  
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Table 4-1 Summary of the study populations 
Study Number Study period Inclusion 
criteria 
Mortality n(%) MOF n(%) ICU-LOS >5d 
n(%) 
 I 98 5th Aug -15th 
Sept1996 
Consecutive 13(13.3) 14b(14.3) 17(17.3) 
 II 83 1st Aug 1998-31th 
July 1999 
Lact >2 and/or 
BE <-4 
33(39.8) 47a(56.6) 27(32.5) 
Total 181   46(25.4) 84(46.4) 44(24.3) 
 III 69c 5th Aug -1st Sept 
1996 
Consecutive 8(11.6) 12b(17.4) 14(20.2) 
       
 IV 23953d From 1994 to 1999 All patients 
with full data 
2356(19.8) No data 1915(16.1) 
a Definition: Sofa score > 2 of 2 or more organ systems  
b Definition of Ruokonen et al. Crit Care Med 1991 
c First 69 consecutive patients of the Study I patients 
d Split into calibration and validation data of equal size 
 
4.2 Sample size considerations  
For the lactate study (study I), sample size was estimated based on the patient selection of 
emergency admissions of ICU of Kuopio University Hospital. Hospital mortality at the institution 
is 8-12 % in elective patients and higher in emergency patients. The study group of 100 patients 
was estimated to include more than 10 patients ultimately dying in hospital and to be large enough 
to allow conclusions about the predictive role of hyperlactatemia in terms of mortality. The study 
patients for the sampling rate study (study III) were a subgroup of 69 patients of the lactate study 
group. The study population of the Study II was formed retrospectively by studying patient 
records. The ICU of Kuopio University Hospital receives about 940 emergency admissions per 
year. One third of these are neurosurgical patients. The ICU-LOS of 250 patients exceeds 2 days 
and they are thus at risk of having MOF. The first check of patient records of one year identified 
210 candidates for the study. Patients not having pulmonary artery catheter monitoring and not 
fulfilling the inclusion criteria of the study reduced the number of study patients to 83. Because 
the emergency patients have a hospital mortality of 20%, this group was estimated to include at 
least 20 deaths. The prediction model study (study IV) was based on a large national database and 
all admissions at the end of previous year before the start of the study were included. 
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4.3 Ethical considerations  
Informed consent was waived in studies I and III because no therapeutic manipulations were 
done and because only minimal amounts of blood were collected from indwelling arterial lines. 
Arterial lines were part of the routine protocol in the care of the patients. The study II was a 
retrospective analysis of patient data. The study IV was carried out in a large national database 
and the use of the database for research purposes was approved by the board of the Consortium 
and by responsible authorities of all participating ICUs. All studies were approved by the ethics 
committee of the Kuopio University Hospital.  
4.4 Study protocol 
4.4.1 Time-pattern on lactate and L/P-ratio (Study I) 
4.4.1.1 Sampling protocol 
In order to study the time-pattern of lactate and L/P-ratio in 98 emergency admission 
patients, blood samples for the measurement of arterial lactate, pyruvate and the blood gases were 
taken at the time of admission and at two hours intervals during the next 24 hours or until earlier 
discharge or death of the patient. The attending physician had access only to the lactate and blood 
gas values taken on clinical basis. On average 20.5% (range 15.6 – 28.1% between diagnostic 
groups) of the total number of lactate samples were taken on clinical basis. 
4.4.1.2 Laboratory analysis 
The blood samples for the lactate and pyruvate determination were drawn from indwelling 
arterial lines and put in ice immediately after sampling. The blood lactate samples were analysed 
without delay in the ICU using an amperometric enzyme sensor method (YSI 2300 Stat Plus, YSI 
Incorporated, Yellow Springs, Ohio, USA). The lactate measurements had an intra-assay 
coefficient of variation of 1.9% and 1.7% with control samples of 2.0 and 11.4 mmol/L, 
respectively. The inter-assay coefficient of variation was 3.6% and 1.8% with control samples of 
2.0 and 10.7 mmol/L, respectively. The blood pyruvate samples were deproteinised and 
centrifuged without delay in the clinical laboratory of the ICU and the supernatants were frozen to 
-80°C. They were analysed after a maximum of 4 days of storage in sets using an enzymatic 
colour reaction (Sigma UV-706 kit, Sigma Diagnostics, St.Louis, MO, USA) and a 
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spectrophotometer (Shimadzu CL-750, Shimadzu Corporation, Kyoto, Japan). Analyses of each 
individual patient were performed within the same set of tests. The pyruvate-analyses had an 
inter-assay coefficient of variation of 2.7%, 2.9% and 5.0% with control samples of 200, 169 and 
100 mmol/L, respectively. The intra-assay coefficient of variation was 4.4%. The blood gas 
measurements were done immediately after sampling in the laboratory of the intensive care unit 
(Radiometer ABL-500, Radiometer, Copenhagen, Denmark). 
4.4.1.3 Determination of the cut-off values for lactate and L/P-ratio 
The lactate value less than 2 mmol/L was considered normal, which has been commonly 
used as a cut-off value for lactate in intensive care studies. The reference value of L/P-ratio was 
determined in 50 healthy volunteers. The median value of L/P-ratio of the volunteers was 10.0 
(IQR 8.1-11.5). Because of not normal distribution of the L/P-ratio, calculation of a mean value 
and determination of 2.5 and 97.5 percentiles was performed with logarithmic values. These 
calculations gave a reference range of 5.1-18.0 for the L/P-ratio in healthy volunteers and that was 
used in the study.  
4.4.1.4 Definitions  
Circulatory shock was defined either as hypovolemic shock or as the need for 
sympathomimetic drugs and/or vasodilators (excluding vasodilator treatment for arterial 
hypertension alone) to support circulation (septic and cardiogenic shock). Hypovolemic shock was 
defined based on a clinical history of acute bleeding requiring surgical intervention and fluid 
resuscitation. Septic shock was defined as sepsis with the need for adrenergic drugs to maintain 
blood pressure (Ruokonen et al 1991). Circulatory shock was considered to be cardiogenic if the 
patient received inotropes or vasodilators to enhance cardiac performance and was not in 
hypovolemic or septic shock. In the study I, MOF was considered to be present if the ICU-stay 
was more than 2 days and at least two of the following were present at the same time: a) Glasgow 
Coma Scale < 10 in the absence of sedation; b) dependence on mechanical ventilation; c) 
vasoactive drug infusion to treat hypotension or decreased cardiac output; d) serum bilirubin 
concentration > 40 mmol/L and serum alanine aminotransferase > 40 U/L; e) serum creatinine 
concentration > 200 mmol/L, urine output < 750 mL/24hrs in the absence of hypovolemia or the 
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need for acute dialysis; f) platelet count < 80 x 109/L and leukocyte count < .5 x 109/L; g) 
macroscopic gastrointestinal bleeding or paralytic ileus (Ruokonen et al 1991).  
4.4.2 Circulatory failure (Study II) 
The first ICU-day of each study patient was reconstructed by producing identical sets of 
trend curves as in the original clinical situation using the CIMS (Clinical information management 
system, Clinisoft Datex-Ohmeda, Helsinki, Finland) of the unit. The trend curves consisted of all 
hemodynamic data, temperatures, urine output, Glasgow Coma Scale (GCS), blood gases, arterial 
lactate, pulse oximetry readings and infusions rates of vasoactive drugs. Continuously measured 
variables were stored in the database as two-minute median values and other variables were stored 
as often as they were measured. The nursing staff performed hourly controls of patient status. 
These included cardiac filling pressures, cardiac output, urine output and GCS and they were 
stored in the data management system as well. Laboratory tests were taken when clinically 
indicated. Treatment recordings consisted of vasoactive therapy and other medication, as well as 
of volumes of infusions of crystalloids, colloids and blood products given. The dosages of 
vasoactive treatment were calculated as far as they were necessary for SOFA scoring. A 
combination medication could be administered simultaneously or in sequence. Dobutamine or 
dopamine were used as inotropes and as other sympathomimetic drugs norepinephrine or 
epinephrine were used. Sodium nitroprusside or nitroglycerin were used as vasodilators. For the 
purpose of describing patient characteristics, patients were divided into 6 diagnostic categories 
based on the immediate cause of admission: cardiovascular, respiratory, infection, trauma, cardiac 
arrest and others. These categories are used in our ICU with the exception that trauma and surgical 
patients were put into the same group. Patients were considered to have sepsis if at least two of the 
following were present simultaneously: body temperature > 38°C or < 36°C, heart rate > 90 
beat/min, respiratory rate >20 breaths/min or paCO2 < 4.3 kPa, WBC > 12,000 cells/mm3 or > 10% 
immature forms and a known source of infection (Bone, et al. 1992a). In all cases either a positive 
microbial culture or obvious source of infection was identified. The later course of the ICU-care 
and possible development of MOF of each patient were characterised with daily SOFA–scores. 
SOFA-scores were calculated using the published threshold values and using the available 
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laboratory tests and CIMS (Vincent, et al. 1996). If adjacent values were present, the missing 
value was interpolated. If more than one value was missing, they were not interpolated and were 
scored as missing and giving 0 points. This process of interpolation was necessary only for 
bilirubin values. If more than one value was available for the particular day, the worst i.e. the most 
points giving value was chosen. In order to describe the involvement and severity of different 
organ failures, the total maximal SOFA-score (TMS-score) was calculated. This was done by 
summing the maximum scores of each 6 organ systems during the whole ICU-period. The 
theoretical maximum of TMS-score is thus 24. In order to describe the evolution of MOF, an extra 
variable, time to peak-TMS was determined as the ICU-day during which the TMS-score reached 
its maximum. 
4.4.3 The effect of sampling rate on the severity scores (Study III) 
Two regimes of sampling of laboratory values and of monitored values contained in the 
severity scores were followed. The first set of laboratory tests was collected taking the needed 
tests by the time of admission and thereafter only when prescribed by the clinical staff. In addition 
the laboratory tests were collected at two hours intervals for the first 24 hours or until earlier 
discharge or death of the patient. Monitored values of hemodynamic and respiratory status as well 
as of temperature were recorded in two different ways. First, all monitored variables needed for 
the severity score calculation were manually stored into the database of the ICU at one hour 
intervals by the attending nurse, simulating a traditional manual record keeping. Simultaneously, a 
second set of data was collected automatically with the CIMS as two-minute median values. 
Using the obtained values, three sets of APACHE II and SAPS II scores were calculated. 
Manually collected hemodynamic data and clinically indicated laboratory data were used to 
calculate traditional severity scores (APACHETRAD and SAPSTRAD). Automatically collected 
monitor data and clinically indicated laboratory data were used to calculate a set of severity scores 
describing the effect of CIMS (APACHECIMS and SAPSCIMS). A high sampling rate data was 
collected when automatically collected monitor data and laboratory values on 2 hours intervals 
were used (APACHEHIGH and SAPSHIGH). SAPS II and APACHE II scores were used to calculate 
the risk of hospital death according to the original formulae. For the calculation of the risks of 
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hospital death, 2 patients with burn injuries and 3 coronary surgery patients were excluded 
because no diagnostic category weight is determined. One of these patients died. 
4.4.4 The effect of prolonged ICU stay on the mortality prediction using severity scores 
(Study IV) 
4.4.4.1 Data collection 
ICUs in nine central hospitals in Finland started the “Finnish Consortium of Intensive Care 
Data” by collecting data for Acute Physiology and Chronic Health Evaluation II (APACHE II) 
and Simplified Acute Physiologic Score II (SAPS II) calculations in the year 1994. For the study, 
data of the years from 1994 to 1999 was used and during that time the number of participating 
units increased to 13. The practice of data collection was standardised and advised before the start 
of the process and at least once a year thereafter in collaborative meetings. Data was collected by 
a trained nurse or a physician. Data for Therapeutic Intervention Scoring System (TISS) was also 
collected and used as a sum of each ICU admission to reflect the consumption of ICU-resources. 
In the years 1994 and 1995 the most deranged values for the score calculations were picked up by 
the responsible doctors in each unit. Starting 1996, both the highest and the lowest value of each 
variable were recorded and the most points giving values picked up automatically by a tailor-made 
computer program. In 1994-1996 data were entered to the database manually by three specially 
trained assistants who checked the forms for major errors. In 1997-1998 optical character 
recognition and centralised computerised error checking were performed, and in 1999 
computerised checks for major errors were done during the data entry procedure. The study 
database was formed after exclusion of patients under the age of 18, patients admitted for 
observation only as well as re-admissions and coronary surgery patients. Data of 1036 admissions 
were missing or not complete. From 30333 admissions collected, 23953 formed the study 
population. 
4.4.4.2 Customisation of the APACHE II and SAPS II prediction models  
The performance of the risk calculations of hospital death with the published formulae was 
tested: Risk calculations with the original formulae (Knaus, et al. 1985, Le Gall, et al. 1993):  
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APACHE II: R/(1-R) = e –3,517 + (APACHE II * 0.146) + 0.603 (if emergency surgery) + diagnostic category weight  
SAPS II: R/(1-R) = e –7,7631 + (0.0737*SAPS II) +0.9971 * ln (SAPS +1) 
R = Risk of hospital death 
Performance of these original scores was not satisfactory and therefore a customisation 
process was undertaken. This was done by dividing the study population randomly into two 
equally sized halves, a calibration data set of 12064 admissions and a validation data set of 11889 
admissions. Random division was performed with the SPSS-statistical program. The only 
difference between the calibration and validation data set was the slightly higher mean age of men 
in the validation data set. Logistic regression analysis was performed in the calibration data by 
using hospital death as the outcome variable. For the customised APACHE model, APACHE II 
score, diagnostic category weight as originally published by Knaus (Knaus, et al. 1985a) and 
emergency operative status were entered simultaneously as independent variables. For the 
customisation of the SAPS model, SAPS II score and the ln(SAPS +1) variable were entered. The 
logistic regression analysis resulted in correction factors for all the independent variables and 
using these new coefficients, new formulae for the calculation of the risk of hospital death were 
formed. 
Customised APACHE model:  
R/(1-R) = e -4.0032 + (APACHE II * 0.1483) + (0.0143 if emergency surgery) + (0.6792 * diagnostic category weight).  
 
Customised SAPS model:  
R/(1-R) = e –4.5051 + (0.0817*SAPS II) –0.0183 * ln (SAPS +1).  
These formulae were used for the calculation of risk of hospital death in the validation data set. 
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5 STATISTICAL METHODS 
5.1 Data presentation and statistical tests  
Data are presented as mean ± SD or as median with IQR (inter quartile range) depending on 
the distribution characteristics of the data. Logarithmic or square root transformations of the data 
were performed if it was necessary to get the data normally distributed for the analyses. Data were 
analysed with T-test or with Mann-Whitney test, according to the distribution characteristic of 
data. Data in 2x2 and 2x3 tables were analysed with chi-square test and Yates correction was 
applied if appropriate. Per cent distributions between two groups were analysed with Fisher´s-
exact test. Standardised mortality ratio (SMR) was calculated by dividing the number of observed 
deaths by the number of expected deaths. The number of expected deaths was calculated by 
summing the probabilities of death. Confidence intervals of the SMR were calculated using the 
proposed methods (Gardner and Altman 1989). 
5.2 Special statistical considerations. 
Study I 
The L/P-ratio values refer to the concurrent L/P-ratio values coinciding with the peak lactate 
values. A univariate logistic regression model was used to calculate the odds ratio for hospital 
death comparing hyperlactatemic and subgroups of hyperlactatemic patients with normolactatemic 
patients. The risk coefficients are reported with 95% confidence intervals and p-values. 
Study III 
The contribution of the variables to the changes of the scores between high and low sampling 
rate was calculated by relating the change of the score of every variable to the total change of the 
score and separately to the hemodynamic or laboratory scores. 
Study IV 
The calibration of the prediction models was tested using Hosmer-Lemeshow goodness-of-fit 
procedure. The H* statistics was calculated by dividing the admissions into 10 deciles according 
to increasing risk of death. The chi-square sta tistics was determined for each decile and summing 
the 10 chi-square values resulted in H*. A high p-value (>0.05) indicates a good fit of the model. 
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The discrimination of the models was studied by Receiver Operating Characteristic (ROC)-curves 
and corresponding areas under the curves (AUC). 
All statistical procedures were performed using SPSS 9.0 statistical package (SPSS Inc., 
Chicago, Illinois USA). 
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6 RESULTS 
6.1 Lactate and L/P-ratio in emergency ICU-admissions  
Thirty patients had circulatory shock: Hypovolemic shock was found in 8 patients, septic 
shock in 8 patients and cardiogenic shock in 14 patients. There were 31 neurosurgical patients and 
37 patients in other diagnostic groups. Forty-eight patients (49%) had lactate values above the cut-
off value of 2 mmol/L during the first ICU-day. Thirty-one patients had hyperlactatemia at the 
time of admission and 17 developed lactate elevations during the first day. In 16 patients the 
hyperlactatemia was accompanied with L/P-ratio elevation at some point during the observation 
period. The majority of patients with circulatory shock (76.7%) had hyperlactatemia at some time 
point and in 16 cases (53%) it was present at the time of admission. The patients with circulatory 
shock had in 8 cases (27% of all patients with circulatory shock) a simultaneously elevated lactate 
and L/P-ratio. In 8 out of 9 cases with lactic acidosis, the lactate elevation was accompanied with 
L/P-ratio elevation. The non-survivors had higher peak lactate values (5.3[1.9-7.5]mmol/L) than 
the survivors (1.9[1.3-2.9]mmol/L, p=0.003). If the admission hyperlactatemia persisted longer 
than 6 hours, the mortality was 36.8% in contrast to short lasting admission hyperlactatemia, 
which was not associated with mortality (p=0.032). Hyperlactatemia developing during the first 
ICU-day after admission was not associated with significant mortality (1 patient, 5.9%). The risk 
estimates of patterns of hyperlactatemia with and without L/P-ratio elevation compared to patients 
with normal lactate levels is presented in Table 6-1. The OR of lactic acidosis compared to 
patients with normal lactate was 31.3(CI95% 5.1-191.8, p= 0.0002) and LR+ was 11.1.  
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Table 6-1 The association of different patterns of lactate elevation with or without L/P-ratio 
elevation with morta lity. Odds ratio and p-values refer to risk of dying of patients with lactate 
elevation with or without L/P-ratio elevation compared to patients with normal lactate. LR+ refers 
to subgroups of patients with hyperlactatemia compared to patients without lactate elevation for 
prediction of hospital death. 
 Number ODDs ratio p-value Mortality LR+ 
 /non-surv. (95% CI)    
Lactate > 2 48/13 4.1 0.04 13.3% 1.9 
  (1.1-16.0)    
Admission hyperlactatemia  
persisting > 6 hours 19/7 13.4 0.003 36.8% 3.6 
  (2.5-73.1)    
Lactate >2 and L/P-ratio > 18 16/6 9.4 0.003 37.3% 3.8 
  (2.0-44.0)    
 
6.2 Results of the acute circulatory failure study 
ICU mortality of the study group was 33.7% (28 out of 83) and hospital mortality 39.8% (33 
out of 83). Fifty-two patients (63%) responded to the treatment and the signs of perfusion failure 
subsided during the first 24 hours, while 31 patients (37%) were non-responders with a persisting 
circulatory failure. There was no difference in APACHE II scores between these groups (p = 0.1). 
The ICU-LOS of responders and non-responders were equal (p = 0.38). There was a trend towards 
higher hospital mortality of the non-responders compared to the responders (55% vs. 33%, p = 
0.07, LR+ 1.6). The only hemodynamic measure with significance in terms of resuscitation 
outcome or mortality was the mean arterial pressure at 24 hours after admission and it was higher 
in responders than in non-responders. The variables measured with PA-catheter were not 
associated with the resolution of perfusion failure. DO2I did not differ between responders and 
non-responders or between survivors and non-survivors. The non-responders received more 
crystalloids (3254ml[1300-7096] vs. 1489[383-2992], p = 0.0006) and colloids (950ml[475-1900] 
vs. 475ml[202-950], p = 0.001) than the responders, respectively. TMS-scores of the non-
responders (12[9-16]) were higher than of the responders (10[7-12], p=0.019) and the difference 
was enhanced if only patients with ICU-LOS > 2 days were considered (Figure 6-1). 
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Figure 6-1  The development of MOF as described with TMS-scores in responders and non-
responders of the resuscitation from acute circulatory failure. Only patients with ICU-LOS > 2 
days are included. p-value refers to Mann-Whitney U-test.  
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The responders had lower daily SOFA-scores on days 1 (p = 0.006), 2 (p < 0.001) and 3 (p = 
0.001) than the non-responders but not later on. In order to find remote organ failures, emerged as 
a consequence of the circulatory failure, TMS scores were calculated without the inclusion of 
circulatory failure points. TMS-scores without circulatory failure were higher in the non-
responders (9[8-12]) than in the responders (8[6-10], p = 0.014). TMS-scores of the non-survivors 
were higher (13.0 [11-17]) than of the survivors (8.0 [7-12], p < 0.001). Hospital mortality of 
patients with TMS-scores < 5, 6 - 10, 11 - 15 and > 15 were 0%, 27%, 45% and 79%, 
respectively. TMS-score without circulatory failure of the non-survivors (10[9-13]) was higher 
than of the survivors (7[6-9], p < 0.001). The organ specific components of TMS- score were 
analysed separately. Points of coagulation (2[1-3) vs. 3[2-4], p =0.02), central nervous system 
(1[0-2] vs. 3[3-4], p<0.001), renal (1[0-2] vs. 2[2-3], p=0.04) and cardiovascular function (2[1-3] 
vs. 3[3-4], p=0.005)  were different between the survivors and the non-survivors, respectively. 
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There were no differences in respiratory and liver points between the survivors and the non-
survivors. Mortality increased with time from admission to peak-TMS (Figure 6-2). 
 
Figure 6-2 The effect of the time to reach the peak TMS on mortality. 
0
10
20
30
40
50
60
< 3 days 3-5 days > 5 days
Time to peak TMS
N
um
be
r 
of
 p
at
ie
nt
s
Non-survivors
Survivors
 
p = 0.005 for a difference in mortality between groups, Chi square-test. 
 
When the time to peak-TMS was less than 3 days, the mortality was 28% and when the time 
to peak-TMS was 3 – 5 days, the mortality was 47%. In patients with the time to peak-TMS over 
5 days, only 3 out of 13 patients were discharged alive from the hospital. Daily SOFA-scores of 
the non-survivors were higher than the scores of the survivors on days 1 (p < 0.001), 2 (p > 0.001) 
and 3 (p = 0.001). Later on there was no difference in SOFA-scores between survivors and non-
survivors. The non-survivors had higher APACHE II scores (27[24-31] than the survivors (21[17-
26], p < 0.001). 
6.3 Results of the sampling-rate study 
The APACHE II and SAPS II scores increased stepwise as sampling rate was elevated. The 
APACHE II score changed from 15.3 +/- 7.8 to 16.5+/-7.9 (+7.8%, p < 0.001) if CIMS was used 
for collection of continuously measured variables and further to 17.5+/-8.3 (+14.4%, p < 0.001) if 
also laboratory data was collected in 2 hours intervals. The SAPS II scored increased from 35.0+/-
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16.6 to 39.1+/-17.8 (+11.5%, p <0.001) by applying high-resolution data collection with CIMS 
and to 40.5+/-18.6 (+14.5%, p < 0.001) when also laboratory data was collected with elevated 
resolution. The relative contribution of the variables of the severity scores to the maximum effect 
of increase in sampling rate is presented in Table 6-2. 
 
Table 6-2 The relative contribution of the variables of the severity scores to difference between 
traditional and high sampling rate of data collection. 
 
  APACHE II SAPS II 
Hemodynamic and 
respiratory variables 
Heart rate 35.2 % 29.6 % 
 Blood pressure 56.2 % 70.4 % 
 Temperature 1.0 % 0.0 % 
 Respiratory rate 7.6 %  
 Contribution to the total difference 55 % 75 % 
    
Laboratory variables Oxygenation 21.5 % 52.1 % 
 Leukocytes 18.5 % 16.4 % 
 Renal function 4.6 % 9.6 % 
 Potassium 15.4 % 17.8 % 
 Sodium 0.0 % 4.1 % 
 pH/HCO3 7.7 % 0.0 % 
 Hematocrit 32.3 %  
 Contribution to the total difference 45 % 25 % 
 
The risk of hospital death calculated from APACHETRAD and APACHEHIGH was 0.21 ± 0.22 
and 0.25 ± 0.25, respectively (difference 19.5%, p < 0.001). The risk of hospital death calculated 
from SAPSTRAD and SAPSHIGH was 0.23 ± 0.24 and 0.31± 0.28, respectively (difference 34.8%, p 
< 0.001). Because eight patients died in hospital, the SMR decreased from 0.60 (CI95% 0.25-
1.18) to 0.50 (CI95% 0.21-0.99) when APACHEHIGH values were used instead of APACHETRAD 
values and from 0.53 (CI95% 0.23-1.07) to 0.41 (CI95% 0.17-0.81) when using the SAPSHIGH 
values instead of the SAPSTRAD values. Because of the small number of patients in the study, the 
differences of SMR were not significant. 
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6.4 Results of the APACHE and SAPS models in patients with prolonged ICU-LOS 
The resource utilisation of the validation population is presented in Table 6-3. Patients with 
ICU-LOS over 7 days were 11% in number but consumed 56.2% of ICU-days and collected 
51.7% of all TISS-points. Performance of the recalibrated prediction models is presented in Table 
6-4 and Figure 6-3. 
 As the ICU-LOS increased up to 7 days, the prediction models lost their predictive power. 
Fifty-two per cent of all deaths occurred in patients who stayed in the ICU less than 2 days (Figure 
6-4).  
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Table 6-3 Resource utilization and outcome of the predictive models according to the length of 
ICU stay (ICU-LOS) in the validation database. 
 ICU-LOS (days) 
 All £1 >1, £2 >2, £3 >3, £7 > 7 
Number of admissions 11889 4639 2784 1264 1890 1312 
Resource utilisation       
Per cent of admissions 100 39.0 23.4 10.6 15.9 11.0 
Per cent of ICU-days 100 7.4 10.4 7.9 21.6 52.6 
Per cent of TISS-points 100 9.9 10.5 7.4 20.6 51.7 
Outcome        
Number of non-survivors 2356 813 423 243 419 458 
Hospital mortality % 19.8 17.5 15.2 19.2 22.2 34.9 
 
 
Table 6-4 Performance of the recalibrated prediction models in patients with varying ICU-LOS 
   ICU-LOS (days) 
APACHE model All £1 >1, £2 >2, £3 >3, £7 > 7 
H* statistic  11.1 105.6 24.1 13.1 36.1 221.5 
p-value, df 9 0.27 <0.001 0.004 0.158 <0.001 <0.001 
ROC-AUC 0.84 0.91 0.86 0.81 0.76 0.65 
(95%CI of AUC) (0.83-0.85) (0.89-0.92) (0.84-0.88) (0.78-0.84) (0.74-0.79) (0.61-0.68) 
       
SAPS model       
H* statistic  b 8.9 112.7 30.6 6.8 41.6 306.3 
p-value, df 9 0.447 <0.001 <0.001 0.658 <0.001 <0.001 
ROC-AUC 0.83 0.91 0.85 0.79 0.74 0.62 
(95%CI of AUC) (0.82-0.84) (0.90-0.92) (0.83-0.87) (0.76-0.83) (0.72-0.77) (0.59-0.66) 
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Figure 6-3 Calibration curves of the customised APACHE (above) and SAPS (below) models in 
patients with varying ICU-LOS. The corresponding statistics of the curves is presented in table 
6-4. 
0
10
20
30
40
50
60
70
80
90
100
0-1
0
10-
20
20-
30
30
-40
40
-50
50
-60
60
-70
70-
80
80-
90
90-
100
Expected mortality
O
bs
er
ve
d 
m
or
ta
lit
y
perfect fit
all
1-2 days
2-3 days
3-7 days
>7 days
0
10
20
30
40
50
60
70
80
90
100
0-1
0
10-
20
20-
30
30-
40
40-
50
50-
60
60-
70
70-
80
80-
90
90
-10
0
Expected mortality
O
bs
er
ve
d 
m
or
ta
lit
y
perfect fit
all
1-2 days
2-3 days
3-7 days
>7 days
 
75 
Figure 6-4 The relative proportions of ICU and hospital deaths in patients with varying ICU-LOS 
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7 DISCUSSION 
This study shows that lactate elevation is often caused by circulatory failure and that rapid 
resolution of hyperlactatemia is associated with more favourable outcome than long persisting 
hyperlactatemia. Hyperlactatemia with simultaneous L/P-ratio elevation is often seen in patients 
with serious circulatory impairment and these patients have often a lactic acidosis as well. Success 
of resuscitation from acute circulatory failure is not associated with any circulatory pattern 
obtainable with pulmonary artery catheter. Failed resuscitation from acute circulatory failure in 24 
hours is associated with increased risk of MOF as reflected in TMS-scores. Late worsening of 
MOF is associated with increased risk of death. The more organ failures are involved and the 
more severe the present organ failures are, the higher is the mortality. Increasing the sampling rate 
of data collection for the APACHE II and SAPS II scores results in higher scores and alters the 
outcome prediction. Mortality prediction models based on APACHE II and SAPS II scores are not 
reliable in patients with prolonged ICU stay even after recalibration to local patient population. 
Circulatory failure is the main cause of lactate elevation. Other causes of lactate elevation, 
such as the use or endogenic production of epinephrine, respiratory alkalosis, diminished lactate 
clearance in acute liver failure and most importantly, lactate production induced by metabolic 
alterations in sepsis, are all associated with the acute phase of critically ill patients. The etiology 
of lactate elevation cannot be determined in detail in a clinical situation. In the study, sepsis was 
only rarely causing hyperlactatemia. In hypovolemic and cardiogenic shock, increased blood 
lactate concentrations can reflect anaerobic metabolism due to hypoperfusion, but the 
interpretation of blood lactate concentrations in septic patients is more complicated. Increased 
lactate concentration may result from cellular metabolic changes impairing the oxygen availability 
rather than from global hypoperfusion and in those circumstances increasing systemic oxygen 
delivery fails to normalise increased lactate concentrations (Gore, et al. 1996, Brealey, et al. 
2002). 
The rate of lactate clearance, despite of the etiology of hyperlactatemia, is of outmost 
importance to the outcome of the patients. If the admission hyperlactatemia lasted longer than 6 
hours, the risk of death was markedly higher than in patients with normal lactate values. None of 
77 
the patients who could clear their lactate values in 6 hours died and only one patient with 
subsequent hyperlactatemia died. The hyperlactatemia developing during the first ICU day is 
often of low level and caused by metabolic changes induced by therapy. Because the 
neurosurgical patients had most often either cerebral trauma or subarachnoid bleeding, the applied 
hyperventilation might have triggered the moderate level lactate elevations (Druml, et al. 1991).  
Hyperlactatemia was rarely (33% of all hyperlactatemic patients) associated with L/P-ratio 
elevation. There was no support for the assumption that increased L/P-ratio is more common in 
patients with circulatory failure (Hotchkiss and Karl 1992) because the share of patients in 
circulatory failure and with hyperlactatemia combined with L/P-ratio elevation was not different 
from patients without circulatory impairment. Though the addition of L/P-ratio to the lactate 
measurement increased the predictive power of lactate alone, simultaneously elevated L/P-ratio 
and lactate was overlapped by lactic acidosis and thus, its diagnostic value in daily practice is 
diminished by this. The patients with lactic acidosis were often severely sick and often had 
circulatory failure. Because of its difficult handling, L/P-ratio is prone to pre-analytical errors, 
which makes it an unpractical tool for everyday use. 
Most studies on lactate have dealt with specific patient groups like trauma (Abramson, et al. 
1993) and sepsis or septic shock (Tuchschmidt, et al. 1989, Bakker, et al. 1991, Bernardin, et al. 
1996). Most studies have used sampling intervals determined by clinical practice or the clinical 
course of the patients (Bakker, et al. 1991) or timely fixed sampling times such as every 8 
(Abramson, et al. 1993, Manikis, et al. 1995) or 24 hours (Bernardin, et al. 1996). Smaller 
intervals have been used only in brief studies (Vincent, et al. 1983). The applied approach of this 
study facilitated the description of the pattern of lactate and L/P-ratio in detail during the first day 
and also to detect hyperlactatemia developing after admission. 
The normal range of lactate in healthy volunteers is considerably lower than the generally 
accepted threshold range of 2 – 2.5 mmol/L in critically ill patients. For this study the 
hyperlactatemia was considered to be present if lactate was over 2 mmol/L (Abramson, et al. 
1993, Bakker, et al. 1996). The normal range of L/P-ratio is more complicated. The normal value 
of L/P-ratio has been set to a level of 10 since the times of Huckabee (Huckabee1958a) and we 
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found similar mean values in healthy volunteers. L/P-ratio has been shown to be in the range of 20 
in patients with sepsis and around 40 in patients with cardiogenic shock (Levy, et al. 2000). The 
level of 10 is according to our results too low for intensive care patients and we used the level of 
18 after it was determined in healthy volunteers. 
Previous studies of the association of L/P-ratio with mortality have revealed contradicting 
results. Early studies of circulatory shock patients of varies etiologies has showed that the power 
of lactate in predicting mortality was not significantly improved by adding L/P-ratio values to the 
discriminant function analysis (Weil and Afifi 1970). The ROC-AUC of L/P-ratio was slightly 
larger than that of lactate in predicting hospital outcome but the curves were not compared 
statistically with those of lactate alone in later studies (Levy, et al. 2000). 
The present study showed that the successful resolution of circulatory failure defined as 
clearance of hyperlactatemia and/or metabolic acidosis is associated with lower risk of MOF. 
More severe and progressive MOF is associated with increased mortality. Manipulation of 
circulation is the cornerstone of patient care in the intensive care. Most acute problems in 
intensive care are directly resulting from impaired circulation or at least related to circulation as a 
facilitator of tissue oxygenation. Response to treatment in acute circulatory failure, defined as 
disappearance of hyperlactatemia or metabolic acidosis can be used as a measure of successful 
treatment. The definition of acute circulatory failure in our study attempted to identify a group of 
severely sick patients with a high risk of MOF and/or mortality. Previous study has shown that 
resolution of hyperlactatemia and/or metabolic acidosis is associated with favourable outcome 
(Abramson, et al. 1993, Sauaia, et al. 1994, Bakker, et al. 1996). Persistence of occult 
hypoperfusion defined as the presence of elevated lactate levels despite therapeutic efforts have 
been shown to be associated with respiratory complications, MOF and death (Blow, et al. 1999) as 
well as with infectious complications (Claridge, et al. 2000). The findings of our study are in 
agreement with previous studies showing that lactate clearance is not associated with any 
particular pattern of oxygen transport and cardiac performance (Levy, et al. 2000, Bernardin, et al. 
1996). This study does not support the concept of supranormal oxygen delivery as a therapeutic 
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goal to improve mortality or to lower the risk of MOF (Tuchschmidt, et al. 1992, Yu, et al. 1993, 
Boyd, et al. 1993). 
Grading of MOF with SOFA-scores and its sophistication, the TMS-score is suitable for 
clinical trials (Moreno, et al. 1999). The use of daily SOFA score might lead to underestimation of 
the cumulative failures. In TMS scores all organ failures ever present during the ICU-stay in 
question are included. TMS-scores are good predictors of ICU-outcome and the ROC-AUC has 
been shown to be above 0.8 in predicting death (Janssens, et al. 2000). Other studies have found 
that MODS-score and TMS-score are comparable in predicting hospital death (Pettilä, et al. 2002) 
and their basic idea is similar. TMS-score of 15 was associated with high mortality in the present 
study, which is in accordance with previous studies (Moreno, et al. 1999). Also the timing of 
accumulation pattern of MOF measured as the time-to peak TMS was related to mortality. If new 
organ failures appeared or present organ failures worsened after 5 days of care, the prognosis was 
poor. The present results are similar to those found by others (Moreno, et al. 1999, Janssens, et al. 
2000). In the context of MOF-development it is of interest to look for remote organ failures from 
the initial event. The initiating event in our patients was the circulatory failure and with our 
definition all patients had some form of circulatory impairment on the first ICU-day. In order to 
concentrate on the remote organ failures, TMS-scores without cardiovascular points were 
calculated. A similar difference between responders and non-responders was found as with total 
TMS-scores and we can conclude that circulatory failure triggered the organ failures in remote 
organ systems. 
MOF is the most important cause of prolonged ICU-stay. Because MOF patients consume 
large amounts of ICU resources, the prediction of outcome in this patient category is most 
warranted. Accurate prediction of poor outcome would spare the patient unnecessary suffering and 
the hospital wasted resources. Outcome prediction based on the severity scores starts with 
estimation of the severity of acute illness on the day of admission. The severity of acute illness 
together with host factors like admission diagnosis and age is transferred to a probability of death. 
Prediction of outcome can be biased if the score is inaccurate and does not correctly reflect the 
patients status or if the prediction model does not apply to all groups of patients equally. Modern 
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computer technology can save data with nearly unlimited resolution. If the daily measured 
continuous data is stored automatically at two-minute intervals, there are 720 measuring points 
compared to 24 measurements with the traditional rate of once per hour. The present results 
indicate that severity scores are subject to a substantial bias if the sampling rate is changed. The 
results are in accordance with those of Bosman (Bosman, et al. 1998). Adding to his results, the 
impact of increasing the sampling rate of laboratory tests could be estimated separately. High 
sampling resolution of computerised systems includes that all brief events including artefacts are 
also stored. One method of artefact elimination is median filtering, which was used in the 
technology applied in this study (Mäkivirta, et al. 1991). There is no agreement or standard on the 
extent or duration a measurement fluctuation should attain in order to be considered a relevant 
piece of information and not an artefact. The inter-observer variability in the study III was 
eliminated because all data were collected and analysed by the author. Great emphasis was put to 
control the inter-observer variability of data of the study IV. Data collection, definitions and 
interpretation of data were advised and discussed in detail at the start of the project and rehearsed 
thereafter in yearly collaborative meetings. This was especially necessary because of the length of 
the project. 
Patients with prolonged stay form a special group of patients in different ways. Nearly one 
quarter of our patients in studies I and II stayed in the ICU for longer than 5 days. The association 
of MOF and mortality is well documented (Ferreira, et al 2001, Metniz, et al. 2001, Pettilä, et al. 
2002c, Timsit, et al. 2002). The mortality of the patients with prolonged stay is most often related 
to the course of MOF and to host factors (Goins, et al. 1991). If the severity of acute illness and 
the course of MOF are controlled, the differences in outcome are then closely related to 
differences in factors related with organisation, management and quality of care. (Shortell, et al. 
1994, Dimick, et al. 2001). Because the quality of provided care is important for the outcome 
during the prolonged treatment, the outcome of MOF-patients can be a marker of quality of care 
(Johnson and Mayers 2001). The mortality of patients with prolonged stay is higher than of other 
patient groups (Stricker, et al. 2003). These multiple factors can impair the performance of 
prediction models that are based on the data of the first ICU day. (Zhu, et al. 1996). The results of 
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our study showed that prediction models based on APACHE II and SAPS II scores of the first 
ICU day are not applicable in patients staying longer than 7 days in the ICU, though the models 
performed well in patients with short stay in the ICU. This finding is in accordance with previous 
studies (Sleigh, et al. 1992, Sicignano, et al. 1996). Similar results have been found in patients 
with perforated viscus (Barie, et al. 1996a). The weights of the severity scores have not been 
statistically analysed in relation to outcome after prolonged stay and actually most of the weights 
of the APACHE II scores were directly taken from the original APACHE (Knaus, et al. 1985a). 
Barie studied predictions of prolonged critical care in surgical patients and found that APACHE 
III score, emergency admission status and organ failures were independent predictors of 
prolonged stay (Barie, et al. 1996b). Only admission APACHE III score and organ failures were 
independently associated with mortality and the authors state that more weight should be given to 
parameters of organ failures in future predictive models. All non-survivors had MOF and the 
mean ICU-LOS was 12 days, which emphasises the role of MOF as the main cause of prolonged 
stay. Though the mortality of patients with short ICU stay is normally lower than of patients with 
long ICU stay, their high proportion means that majority of deaths occur to patients with short 
stay (Figure 6-5). The performance of prediction models was also satisfactory in these short-
staying patients. It is noteworthy that 57 % of all deaths occurred to patients with a predictive risk 
of death of less than 50%. The predictive instruments in their present form cannot be used to 
predict death in a single patient. The outcome of patients after prolonged ICU care is the result of 
numerous factors. The severity of acute illness, as it is assessed with the severity scores, does not 
allow prediction of outcome. The present study indicates that outcome prediction of patients with 
prolonged ICU should include variables containing response to therapy and development of MOF. 
An important indicator of a positive response to therapeutic measures is the clearance of lactate.  
The present study has some limitations. The small sample size and large number of patients 
with short ICU-LOS in the study I prevents a more rigorous presenting of data according to 
recommendations of using laboratory tests for outcome prediction. ROC-curves could have been 
presented to demonstrate the independent and combined predictive power of lactate and L/P-ratio 
for outcome prediction. In the study II, the most critical question is the possibility of a selection 
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bias, which can arise in post-hoc analysis. It can not be excluded that the selection method picked 
up patients with MOF already developing at the time of admission and that the later therapeutic 
interventions could not have been able to change the course of these patients. This is especially 
true for the patients with re-admissions to the ICU. An analysis of predictive factors using logistic 
models could have identified the independent predictors of mortality and MOF in more detail. 
However, in the early phase of ICU-care, it is not possible to distinguish an early MOF from other 
temporary organ dysfunctions.  
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8 CONCLUSIONS 
On the basis of the present study following conclusions can be drawn. 
· Lactate elevation in unselected emergency admission patients is common and it is often a sign 
of circulatory failure. 
· Prolonged lactate clearance on the first ICU day is associated with increased risk for 
development of multiple organ failure and death. 
· Addition of L/P-ratio to lactate measurement improves the predictive role of lactate 
measurement.  
· Failure in the early resuscitation of circulatory failure increases the risk of MOF but the 
development and progression of MOF determines the final the outcome. 
· General severity scores are subject to considerable bias if the sampling rate of the values for 
variables is changed. 
· Mortality prediction models based on the first day severity scores cannot be used in patients 
with prolonged ICU-stay. 
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9 FUTURE IMPLICATIONS 
The results of this study implicate that the variables of the severity scores should be tested 
for their correlation with the outcome after prolonged intensive care and if they proof not to have 
prognostic significance, other variables should be looked for. Arterial lactate and its evolution 
during the first ICU-day have proved to be a good predictor of outcome. Because of the difficulty 
in determining the exact phase of MOF, the severity scores can actually measure the severity of 
MOF. Severity of the acute disease can be mixed up with developing MOF, which results in errors 
of outcome prediction. Therapeutic efforts are sensitive to the phase of the disease process when 
they are applied (Rivers, et al. 2001). Logistic models can only include variables that are 
independent, linearly associated with the outcome and limited in number. New prediction models 
based on analysis of non-linear complex systems (Seely and Christou, 2000) and on neural 
networks (Dybowski, et al. 1996, Hanisch, et al. 1998) may result in improved outcome prediction 
also in patients with prolonged ICU-stay. These methods are able to handle the great amount of 
data that can be collected and that has value alone or in combinations with other variables for the 
outcome prediction. 
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